# UpdateEmbeddedAnnotations=true,,,,,,,,,,,,,,,
ProbeID,Codeset.Name,Probe.Label,Analyte.Type,Is.Control,Control.Type,Related.Probes,Probe.Annotation,KEGG.Pathways,Cell.Type,Official.Gene.Name,Fusion.Probe.Type,Fusion.Base,SNV.Probe.Type,SNV.LocID,SNV.annot
NM_000038.3:6850,NS_Hs_CART_v1.0,APC,mRNA,0,,,Phenotype;Exhaustion;Wnt signaling;Apoptosis,hsa04310;hsa04390;hsa04550;hsa04810;hsa05166;hsa05200;hsa05206;hsa05210;hsa05213;hsa05217,,APC,,,,,
NM_000546.2:1330,NS_Hs_CART_v1.0,TP53,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;Wnt signaling;Notch;Myc targets;MAPK and PI3K Signaling;Cell Cycle;Apoptosis,hsa04010;hsa04071;hsa04110;hsa04115;hsa04151;hsa04210;hsa04211;hsa04310;hsa04722;hsa04919;hsa05014;hsa05016;hsa05160;hsa05161;hsa05162;hsa05166;hsa05168;hsa05169;hsa05200;hsa05202;hsa05203;hsa05205;hsa05206;hsa05210;hsa05212;hsa05213;hsa05214;hsa05215;hsa05216;hsa05217;hsa05218;hsa05219;hsa05220;hsa05222;hsa05223;hsa05230,,TP53,,,,,
NM_000819.3:370,NS_Hs_CART_v1.0,GART,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00230;hsa00670;hsa01100,,GART,,,,,
NM_000963.1:495,NS_Hs_CART_v1.0,PTGS2,mRNA,0,,,Toxicity;NF-kB,hsa01100;hsa04064;hsa04370;hsa04668;hsa04723;hsa04726;hsa04921;hsa04923;hsa05140;hsa05200;hsa05206;hsa05222,,PTGS2,,,,,
NM_001530.2:1985,NS_Hs_CART_v1.0,HIF1A,mRNA,0,,,Toxicity;Phenotype;Metabolism;Activation;Th17;Notch;Interleukin Signaling;Circadian Clock;Autophagy,hsa04066;hsa04150;hsa04919;hsa05200;hsa05205;hsa05211;hsa05230;hsa05231,,HIF1A,,,,,
NM_001621.3:1900,NS_Hs_CART_v1.0,AHR,mRNA,0,,,Phenotype;Th17;Innate-like T-cells,,,AHR,,,,,
NM_001706.2:675,NS_Hs_CART_v1.0,BCL6,mRNA,0,,,Phenotype;Th1;Tfh,hsa04068;hsa05202,,BCL6,,,,,
NM_002301.2:725,NS_Hs_CART_v1.0,LDHC,mRNA,0,,,Metabolism;Oxidative phosphorylation;Glycolysis,hsa00010;hsa00620;hsa01100;hsa04922,,LDHC,,,,,
NM_002467.3:1610,NS_Hs_CART_v1.0,MYC,mRNA,0,,,Phenotype;Metabolism;Activation;Wnt signaling;TGF-beta;Notch;Myc targets;MAPK and PI3K Signaling;JAK-STAT;Cell Cycle,hsa04010;hsa04012;hsa04110;hsa04151;hsa04310;hsa04350;hsa04390;hsa04550;hsa04630;hsa04919;hsa05161;hsa05166;hsa05169;hsa05200;hsa05202;hsa05205;hsa05206;hsa05210;hsa05213;hsa05216;hsa05219;hsa05220;hsa05221;hsa05222;hsa05230,,MYC,,,,,
NM_003153.3:2030,NS_Hs_CART_v1.0,STAT6,mRNA,0,,,Phenotype;Activation;Th9;Th2;JAK-STAT,hsa04630;hsa05161;hsa05321,,STAT6,,,,,
NM_003234.1:1220,NS_Hs_CART_v1.0,TFRC,mRNA,0,,,Activation;Myc targets,hsa04066;hsa04144;hsa04145;hsa04640,,TFRC,,,,,
NM_004530.2:2360,NS_Hs_CART_v1.0,MMP2,mRNA,0,,,Persistence;T-cell migration,hsa04670;hsa04912;hsa04915;hsa04933;hsa05200;hsa05205;hsa05219,,MMP2,,,,,
NM_004591.1:35,NS_Hs_CART_v1.0,CCL20,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04668;hsa05323,,CCL20,,,,,
NM_006187.2:4980,NS_Hs_CART_v1.0,OAS3,mRNA,0,,,Toxicity;Type II interferon signaling;Type I interferon signaling,hsa05160;hsa05162;hsa05164;hsa05168,,OAS3,,,,,
NM_006332.3:385,NS_Hs_CART_v1.0,IFI30,mRNA,0,,,Toxicity;Activation;Type II interferon signaling;Antigen processing & presentation,hsa04612,,IFI30,,,,,
NM_006732.1:3200,NS_Hs_CART_v1.0,FOSB,mRNA,0,,,Activation;TCR signaling,hsa04380;hsa05030;hsa05031;hsa05034,,FOSB,,,,,
NM_019058.2:85,NS_Hs_CART_v1.0,DDIT4,mRNA,0,,,Metabolism;Activation;mTOR;MAPK and PI3K Signaling;Autophagy,hsa04150;hsa04151;hsa05206,,DDIT4,,,,,
NM_152132.1:465,NS_Hs_CART_v1.0,PSMA3,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;Wnt signaling;Notch;Cell Cycle;Apoptosis;Antigen processing & presentation,hsa03050,,PSMA3,,,,,
NM_181504.2:1105,NS_Hs_CART_v1.0,PIK3R1,mRNA,0,,,Phenotype;Persistence;Metabolism;Exhaustion;Activation;TCR signaling;T-cell migration;mTOR;MAPK and PI3K Signaling;JAK-STAT;Innate-like T-cells;Autophagy;Apoptosis,hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04070;hsa04071;hsa04072;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04261;hsa04370;hsa04380;hsa04510;hsa04550;hsa04611;hsa04620;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04670;hsa04722;hsa04725;hsa04750;hsa04810;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04921;hsa04923;hsa04930;hsa04931;hsa04932;hsa04933;hsa04960;hsa04973;hsa05100;hsa05142;hsa05145;hsa05146;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05169;hsa05200;hsa05203;hsa05205;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05230;hsa05231,,PIK3R1,,,,,
NM_000211.2:520,NS_Hs_CART_v1.0,ITGB2,mRNA,0,,,Toxicity;Persistence;Exhaustion;T-cell migration;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04015;hsa04145;hsa04390;hsa04514;hsa04650;hsa04670;hsa04810;hsa05133;hsa05134;hsa05140;hsa05144;hsa05146;hsa05150;hsa05152;hsa05166;hsa05323;hsa05416,,ITGB2,,,,,
NM_002029.3:350,NS_Hs_CART_v1.0,FPR1,mRNA,0,,,Toxicity;Cell Types;Activation;Interleukin Signaling,hsa04015;hsa04080;hsa05150,Neutrophils,FPR1,,,,,
NM_002115.1:495,NS_Hs_CART_v1.0,HK3,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00051;hsa01100;hsa01200;hsa04066;hsa04910;hsa04930;hsa04973;hsa05230,,HK3,,,,,
NM_000576.2:840,NS_Hs_CART_v1.0,IL1B,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;NF-kB;MAPK and PI3K Signaling;Interleukin Signaling;Innate-like T-cells,hsa04010;hsa04060;hsa04064;hsa04210;hsa04380;hsa04620;hsa04621;hsa04623;hsa04640;hsa04668;hsa04750;hsa04932;hsa04933;hsa04940;hsa05010;hsa05020;hsa05132;hsa05133;hsa05134;hsa05140;hsa05142;hsa05143;hsa05144;hsa05146;hsa05152;hsa05162;hsa05164;hsa05168;hsa05321;hsa05323;hsa05332,,IL1B,,,,,
NM_000584.2:25,NS_Hs_CART_v1.0,CXCL8,mRNA,0,,,Toxicity;Phenotype;Activation;NF-kB;Innate-like T-cells;Chemokine Signaling,hsa04060;hsa04062;hsa04064;hsa04072;hsa04620;hsa04621;hsa04622;hsa04932;hsa04933;hsa05120;hsa05131;hsa05132;hsa05133;hsa05134;hsa05142;hsa05144;hsa05146;hsa05160;hsa05161;hsa05164;hsa05200;hsa05202;hsa05219;hsa05323,,CXCL8,,,,,
NM_000758.2:475,NS_Hs_CART_v1.0,CSF2,mRNA,0,,,Toxicity;Phenotype;Activation;TCR signaling;JAK-STAT;Interleukin Signaling;Innate-like T-cells;Cytotoxicity,hsa04060;hsa04630;hsa04640;hsa04650;hsa04660;hsa04664;hsa04668;hsa05132;hsa05146;hsa05166;hsa05202;hsa05323,,CSF2,,,,,
NM_000956.2:1410,NS_Hs_CART_v1.0,PTGER2,mRNA,0,,,Exhaustion;T-cell exhaustion markers,hsa04024;hsa04080;hsa04750;hsa04924;hsa05200,,PTGER2,,,,,
NM_000074.2:1225,NS_Hs_CART_v1.0,CD40LG,mRNA,0,,,Toxicity;Exhaustion;Activation;TCR signaling;NF-kB;Interactions with Non-lymphoid Cells;Costimulatory Molecules;Activation Markers,hsa04060;hsa04064;hsa04514;hsa04660;hsa04672;hsa05144;hsa05145;hsa05310;hsa05320;hsa05322;hsa05330;hsa05340;hsa05416,,CD40LG,,,,,
NM_000389.2:1975,NS_Hs_CART_v1.0,CDKN1A,mRNA,0,,,Metabolism;Activation;Myc targets;MAPK and PI3K Signaling;JAK-STAT;Cell Cycle,hsa04012;hsa04066;hsa04068;hsa04110;hsa04115;hsa04151;hsa04630;hsa04921;hsa05160;hsa05161;hsa05166;hsa05169;hsa05200;hsa05202;hsa05203;hsa05205;hsa05206;hsa05214;hsa05215;hsa05218;hsa05219;hsa05220,,CDKN1A,,,,,
NM_000572.2:230,NS_Hs_CART_v1.0,IL10,mRNA,0,,,Toxicity;Phenotype;Activation;Treg;TCR signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04068;hsa04630;hsa04660;hsa04672;hsa05133;hsa05140;hsa05142;hsa05143;hsa05144;hsa05145;hsa05146;hsa05150;hsa05152;hsa05169;hsa05310;hsa05320;hsa05321;hsa05322;hsa05330,,IL10,,,,,
NM_000575.3:1085,NS_Hs_CART_v1.0,IL1A,mRNA,0,,,Toxicity;Activation;MAPK and PI3K Signaling;Interleukin Signaling,hsa04010;hsa04060;hsa04210;hsa04380;hsa04640;hsa04932;hsa04933;hsa04940;hsa05020;hsa05132;hsa05133;hsa05140;hsa05152;hsa05162;hsa05164;hsa05321;hsa05323;hsa05332,,IL1A,,,,,
NM_000594.2:1010,NS_Hs_CART_v1.0,TNF,mRNA,0,,,Toxicity;Phenotype;Metabolism;Exhaustion;Activation;Th17;TGF-beta;TCR signaling;NF-kB;mTOR;MAPK and PI3K Signaling;Interleukin Signaling;Innate-like T-cells;Cytotoxicity;Apoptosis,hsa04010;hsa04060;hsa04064;hsa04071;hsa04150;hsa04210;hsa04350;hsa04380;hsa04612;hsa04620;hsa04621;hsa04622;hsa04640;hsa04650;hsa04660;hsa04664;hsa04668;hsa04920;hsa04930;hsa04931;hsa04932;hsa04933;hsa04940;hsa05010;hsa05014;hsa05133;hsa05134;hsa05140;hsa05142;hsa05143;hsa05144;hsa05145;hsa05146;hsa05152;hsa05160;hsa05161;hsa05164;hsa05166;hsa05168;hsa05205;hsa05310;hsa05321;hsa05322;hsa05323;hsa05330;hsa05332,,TNF,,,,,
NM_000595.2:885,NS_Hs_CART_v1.0,LTA,mRNA,0,,,Toxicity;Phenotype;NF-kB;Innate-like T-cells,hsa04060;hsa04064;hsa04668;hsa04940;hsa05166;hsa05168,,LTA,,,,,
NM_000639.1:625,NS_Hs_CART_v1.0,FASLG,mRNA,0,,,Toxicity;Exhaustion;Activation;T-cell exhaustion markers;Myc targets;MAPK and PI3K Signaling;Interleukin Signaling;Cytotoxicity;Apoptosis,hsa04010;hsa04014;hsa04060;hsa04068;hsa04151;hsa04210;hsa04650;hsa04722;hsa04932;hsa04940;hsa05142;hsa05143;hsa05161;hsa05162;hsa05164;hsa05168;hsa05200;hsa05205;hsa05320;hsa05330;hsa05332,,FASLG,,,,,
NM_000660.3:1260,NS_Hs_CART_v1.0,TGFB1,mRNA,0,,,Toxicity;Phenotype;Metabolism;Activation;Treg;Th9;Th17;TGF-beta;MAPK and PI3K Signaling;Interleukin Signaling;Cell Cycle,hsa04010;hsa04060;hsa04068;hsa04110;hsa04144;hsa04350;hsa04380;hsa04390;hsa04672;hsa04932;hsa04933;hsa05140;hsa05142;hsa05144;hsa05145;hsa05146;hsa05152;hsa05161;hsa05166;hsa05200;hsa05205;hsa05210;hsa05211;hsa05212;hsa05220;hsa05321;hsa05323,,TGFB1,,,,,
NM_000966.3:1540,NS_Hs_CART_v1.0,RARG,mRNA,0,,,Phenotype;Vitamin A (RA) signaling,,,RARG,,,,,
NM_001561.4:255,NS_Hs_CART_v1.0,TNFRSF9,mRNA,0,,,Exhaustion;Activation;T-cell exhaustion markers;Costimulatory Molecules,hsa04060,,TNFRSF9,,,,,
NM_001775.2:1035,NS_Hs_CART_v1.0,CD38,mRNA,0,,,Persistence;T-cell migration,hsa01100;hsa04020;hsa04640;hsa04921;hsa04970;hsa04972;hsa05169,,CD38,,,,,
NM_002462.2:1485,NS_Hs_CART_v1.0,MX1,mRNA,0,,,Toxicity;Type I interferon signaling,hsa05162;hsa05164,,MX1,,,,,
NM_002502.2:825,NS_Hs_CART_v1.0,NFKB2,mRNA,0,,,Toxicity;Activation;NF-kB;MAPK and PI3K Signaling,hsa04010;hsa04064;hsa04380;hsa05134;hsa05166;hsa05169;hsa05200;hsa05203,,NFKB2,,,,,
NM_003152.2:3460,NS_Hs_CART_v1.0,STAT5A,mRNA,0,,,Phenotype;Activation;Treg;Th2;Tfh;JAK-STAT,hsa04012;hsa04630;hsa04917;hsa04933;hsa05161;hsa05162;hsa05166;hsa05200;hsa05203;hsa05220;hsa05221,,STAT5A,,,,,
NM_003842.3:565,NS_Hs_CART_v1.0,TNFRSF10B,mRNA,0,,,Toxicity;Exhaustion;Cytotoxicity;Apoptosis,hsa04060;hsa04115;hsa04210;hsa04650;hsa05162;hsa05164,,TNFRSF10B,,,,,
NM_003877.3:1020,NS_Hs_CART_v1.0,SOCS2,mRNA,0,,,Activation;JAK-STAT,hsa04630;hsa04910;hsa04917;hsa04930,,SOCS2,,,,,
NM_004134.4:975,NS_Hs_CART_v1.0,HSPA9,mRNA,0,,,Metabolism;Mitochondrial biogenesis,hsa05152,,HSPA9,,,,,
NM_004155.3:950,NS_Hs_CART_v1.0,SERPINB9,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa05146,,SERPINB9,,,,,
NM_004350.1:2085,NS_Hs_CART_v1.0,RUNX3,mRNA,0,,,Phenotype;Wnt signaling;Th2,,,RUNX3,,,,,
NM_005027.2:3100,NS_Hs_CART_v1.0,PIK3R2,mRNA,0,,,Phenotype;Persistence;Metabolism;Exhaustion;Activation;TCR signaling;T-cell migration;mTOR;MAPK and PI3K Signaling;JAK-STAT;Innate-like T-cells;Autophagy;Apoptosis,hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04070;hsa04071;hsa04072;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04261;hsa04370;hsa04380;hsa04510;hsa04550;hsa04611;hsa04620;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04670;hsa04722;hsa04725;hsa04750;hsa04810;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04921;hsa04923;hsa04930;hsa04931;hsa04932;hsa04933;hsa04960;hsa04973;hsa05100;hsa05142;hsa05145;hsa05146;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05169;hsa05200;hsa05203;hsa05205;hsa05206;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05230;hsa05231,,PIK3R2,,,,,
NM_005356.2:1260,NS_Hs_CART_v1.0,LCK,mRNA,0,,,Toxicity;Activation;TCR signaling;NF-kB;Cytotoxicity,hsa04064;hsa04380;hsa04650;hsa04660;hsa05166;hsa05340,,LCK,,,,,
NM_006811.2:185,NS_Hs_CART_v1.0,SERINC3,mRNA,0,,,Metabolism;Glutamine metabolism,,,SERINC3,,,,,
NM_012448.3:200,NS_Hs_CART_v1.0,STAT5B,mRNA,0,,,Phenotype;Activation;Th2;JAK-STAT,hsa04012;hsa04062;hsa04630;hsa04917;hsa04933;hsa05161;hsa05162;hsa05166;hsa05200;hsa05203;hsa05220;hsa05221,,STAT5B,,,,,
NM_014550.3:3370,NS_Hs_CART_v1.0,CARD10,mRNA,0,,,Toxicity;NF-kB,,,CARD10,,,,,
NM_130837.1:1355,NS_Hs_CART_v1.0,OPA1,mRNA,0,,,Metabolism;Exhaustion;Mitochondrial biogenesis;Apoptosis,,,OPA1,,,,,
NM_138578.1:1560,NS_Hs_CART_v1.0,BCL2L1,mRNA,0,,,Toxicity;Metabolism;Exhaustion;Activation;NF-kB;MAPK and PI3K Signaling;JAK-STAT;Autophagy;Apoptosis,hsa04014;hsa04064;hsa04151;hsa04210;hsa04630;hsa05014;hsa05145;hsa05166;hsa05200;hsa05202;hsa05212;hsa05220;hsa05222,,BCL2L1,,,,,
NM_138930.2:855,NS_Hs_CART_v1.0,DIABLO,mRNA,0,,,Metabolism;Exhaustion;Mitochondrial biogenesis;Apoptosis,,,DIABLO,,,,,
NM_000619.2:970,NS_Hs_CART_v1.0,IFNG,mRNA,0,,,Toxicity;Phenotype;Activation;Type II interferon signaling;Th1;TGF-beta;TCR signaling;JAK-STAT;Interleukin Signaling;Innate-like T-cells;Cytotoxicity,hsa03050;hsa04060;hsa04066;hsa04140;hsa04350;hsa04380;hsa04612;hsa04630;hsa04650;hsa04660;hsa04940;hsa05132;hsa05140;hsa05142;hsa05143;hsa05144;hsa05145;hsa05146;hsa05152;hsa05162;hsa05164;hsa05168;hsa05169;hsa05321;hsa05322;hsa05323;hsa05330;hsa05332,,IFNG,,,,,
NM_000589.2:625,NS_Hs_CART_v1.0,IL4,mRNA,0,,,Toxicity;Phenotype;Activation;Th9;Th2;Th17;TCR signaling;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04151;hsa04630;hsa04640;hsa04660;hsa04664;hsa04672;hsa05140;hsa05162;hsa05310;hsa05320;hsa05321;hsa05330,,IL4,,,,,
NM_002229.2:1155,NS_Hs_CART_v1.0,JUNB,mRNA,0,,,Phenotype;Activation;TGF-beta;TCR signaling,hsa04380;hsa04668,,JUNB,,,,,
NM_002341.1:330,NS_Hs_CART_v1.0,LTB,mRNA,0,,,Toxicity;Phenotype;NF-kB;Innate-like T-cells,hsa04060;hsa04064;hsa05323,,LTB,,,,,
NM_002176.2:610,NS_Hs_CART_v1.0,IFNB1,mRNA,0,,,Toxicity;Phenotype;Activation;Type I interferon signaling;MAPK and PI3K Signaling;JAK-STAT;Innate-like T-cells;Cytotoxicity,hsa04060;hsa04151;hsa04380;hsa04620;hsa04622;hsa04623;hsa04630;hsa04650;hsa05142;hsa05152;hsa05160;hsa05161;hsa05162;hsa05164;hsa05168,,IFNB1,,,,,
NM_000586.2:300,NS_Hs_CART_v1.0,IL2,mRNA,0,,,Toxicity;Phenotype;Activation;Th2;Th1;TCR signaling;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04151;hsa04630;hsa04660;hsa04672;hsa04940;hsa05142;hsa05162;hsa05166;hsa05320;hsa05321;hsa05330;hsa05332,,IL2,,,,,
NM_000417.1:1000,NS_Hs_CART_v1.0,IL2RA,mRNA,0,,,Toxicity;Phenotype;Activation;Th2;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling;Activation Markers,hsa04060;hsa04144;hsa04151;hsa04630;hsa04640;hsa05162;hsa05166,,IL2RA,,,,,
NM_000641.2:1145,NS_Hs_CART_v1.0,IL11,mRNA,0,,,Toxicity;Activation;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa04640;hsa05323,,IL11,,,,,
NM_002190.2:240,NS_Hs_CART_v1.0,IL17A,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa05321;hsa05323,,IL17A,,,,,
NM_002228.3:140,NS_Hs_CART_v1.0,JUN,mRNA,0,,,Phenotype;Exhaustion;Activation;Wnt signaling;TCR signaling;Notch;MAPK and PI3K Signaling;Innate-like T-cells;Apoptosis,hsa04010;hsa04012;hsa04024;hsa04310;hsa04380;hsa04510;hsa04620;hsa04660;hsa04662;hsa04668;hsa04722;hsa04912;hsa04915;hsa04921;hsa04932;hsa04933;hsa05030;hsa05031;hsa05120;hsa05132;hsa05133;hsa05140;hsa05142;hsa05161;hsa05164;hsa05166;hsa05168;hsa05169;hsa05200;hsa05203;hsa05210;hsa05211;hsa05231;hsa05321;hsa05323,,JUN,,,,,
NM_002416.1:1975,NS_Hs_CART_v1.0,CXCL9,mRNA,0,,,Toxicity;Phenotype;Activation;Innate-like T-cells;Chemokine Signaling,hsa04060;hsa04062;hsa04620,,CXCL9,,,,,
NM_002460.1:325,NS_Hs_CART_v1.0,IRF4,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Activation;Type II interferon signaling;Type I interferon signaling;Treg;Th9;Th17;Tfh;T-cell exhaustion markers;Interleukin Signaling,,,IRF4,,,,,
NM_002985.2:280,NS_Hs_CART_v1.0,CCL5,mRNA,0,,,Toxicity;Phenotype;Activation;Innate-like T-cells;Chemokine Signaling,hsa04060;hsa04062;hsa04620;hsa04621;hsa04623;hsa04668;hsa05020;hsa05120;hsa05142;hsa05164;hsa05168;hsa05323,,CCL5,,,,,
NM_003954.1:620,NS_Hs_CART_v1.0,MAP3K14,mRNA,0,,,Toxicity;Exhaustion;Activation;TCR signaling;NF-kB;MAPK and PI3K Signaling;Apoptosis,hsa04010;hsa04064;hsa04210;hsa04380;hsa04660;hsa04668;hsa04672;hsa05120;hsa05166;hsa05169,,MAP3K14,,,,,
NM_004994.2:1530,NS_Hs_CART_v1.0,MMP9,mRNA,0,,,Persistence;T-cell migration,hsa04668;hsa04670;hsa04915;hsa05161;hsa05200;hsa05202;hsa05205;hsa05206;hsa05219,,MMP9,,,,,
NM_005252.2:1475,NS_Hs_CART_v1.0,FOS,mRNA,0,,,Phenotype;Exhaustion;Activation;TCR signaling;MAPK and PI3K Signaling;Innate-like T-cells;Apoptosis,hsa04010;hsa04024;hsa04380;hsa04620;hsa04660;hsa04662;hsa04668;hsa04713;hsa04725;hsa04728;hsa04915;hsa04917;hsa04921;hsa05031;hsa05132;hsa05133;hsa05140;hsa05142;hsa05161;hsa05166;hsa05168;hsa05200;hsa05210;hsa05231;hsa05323,,FOS,,,,,
NM_006084.4:385,NS_Hs_CART_v1.0,IRF9,mRNA,0,,,Toxicity;Activation;Type II interferon signaling;Type I interferon signaling;JAK-STAT,hsa04380;hsa04630;hsa05160;hsa05162;hsa05164;hsa05168;hsa05203,,IRF9,,,,,
NM_006206.3:1925,NS_Hs_CART_v1.0,PDGFRA,mRNA,0,,,Activation;MAPK and PI3K Signaling;JAK-STAT,hsa04010;hsa04014;hsa04015;hsa04020;hsa04060;hsa04072;hsa04144;hsa04151;hsa04510;hsa04540;hsa04810;hsa05166;hsa05200;hsa05206;hsa05214;hsa05215;hsa05218;hsa05230;hsa05231,,PDGFRA,,,,,
NM_006254.3:2165,NS_Hs_CART_v1.0,PRKCD,mRNA,0,,,Toxicity;Metabolism;Exhaustion;Type II interferon signaling;Autophagy;Apoptosis,hsa04062;hsa04270;hsa04530;hsa04666;hsa04722;hsa04750;hsa04912;hsa04915;hsa04930;hsa04931;hsa04933,,PRKCD,,,,,
NM_015675.2:365,NS_Hs_CART_v1.0,GADD45B,mRNA,0,,,Toxicity;Metabolism;Exhaustion;Activation;NF-kB;MAPK and PI3K Signaling;Cell Cycle;Apoptosis,hsa04010;hsa04064;hsa04068;hsa04110;hsa04115,,GADD45B,,,,,
NM_017442.2:985,NS_Hs_CART_v1.0,TLR9,mRNA,0,,,Phenotype;Innate-like T-cells,hsa04620;hsa05142;hsa05143;hsa05144;hsa05152;hsa05162;hsa05168,,TLR9,,,,,
NM_020529.1:945,NS_Hs_CART_v1.0,NFKBIA,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Activation;TCR signaling;NF-kB;Innate-like T-cells;Apoptosis,hsa04024;hsa04062;hsa04064;hsa04210;hsa04380;hsa04620;hsa04621;hsa04622;hsa04623;hsa04660;hsa04662;hsa04668;hsa04722;hsa04920;hsa04931;hsa05120;hsa05131;hsa05134;hsa05140;hsa05142;hsa05145;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05168;hsa05169;hsa05200;hsa05203;hsa05215;hsa05220;hsa05222,,NFKBIA,,,,,
NM_172174.1:1685,NS_Hs_CART_v1.0,IL15,mRNA,0,,,Toxicity;Phenotype;Activation;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04630;hsa04668;hsa04672;hsa05166;hsa05168;hsa05323,,IL15,,,,,
NM_198253.1:2570,NS_Hs_CART_v1.0,TERT,mRNA,0,,,Phenotype;Metabolism;Activation;Wnt signaling;Myc targets;Cell Cycle,hsa05166,,TERT,,,,,
NM_000579.1:2730,NS_Hs_CART_v1.0,CCR5,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04144;hsa05145;hsa05203,,CCR5,,,,,
NM_002090.2:540,NS_Hs_CART_v1.0,CXCL3,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04668;hsa05132;hsa05134,,CXCL3,,,,,
NM_002164.3:50,NS_Hs_CART_v1.0,IDO1,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa01100;hsa05143,,IDO1,,,,,
NM_013351.1:890,NS_Hs_CART_v1.0,TBX21,mRNA,0,,,Phenotype;Cell Types;Th2;Th17;Th1;Innate-like T-cells,hsa05321,Th1 cells,TBX21,,,,,
NM_021947.1:560,NS_Hs_CART_v1.0,SRR,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00260,,SRR,,,,,
NM_197966.1:2095,NS_Hs_CART_v1.0,BID,mRNA,0,,,Toxicity;Exhaustion;Cytotoxicity;Apoptosis,hsa04071;hsa04115;hsa04210;hsa04650;hsa04932;hsa05010;hsa05014;hsa05152;hsa05200;hsa05416,,BID,,,,,
NM_000879.2:105,NS_Hs_CART_v1.0,IL5,mRNA,0,,,Toxicity;Phenotype;Activation;Th2;TCR signaling;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04630;hsa04640;hsa04660;hsa04664;hsa04672;hsa05310;hsa05320;hsa05321;hsa05330,,IL5,,,,,
NM_001001523.1:1350,NS_Hs_CART_v1.0,RORC,mRNA,0,,,Phenotype;Metabolism;Th17;Innate-like T-cells;Circadian Clock,hsa04710;hsa05321,,RORC,,,,,
NM_052872.3:210,NS_Hs_CART_v1.0,IL17F,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;Interleukin Signaling;Innate-like T-cells,hsa05321,,IL17F,,,,,
NM_173214.1:3290,NS_Hs_CART_v1.0,NFAT5,mRNA,0,,,Activation;NFAT,,,NFAT5,,,,,
NM_139266.1:455,NS_Hs_CART_v1.0,STAT1,mRNA,0,,,Phenotype;Activation;Th1;Notch;JAK-STAT;Innate-like T-cells,hsa04062;hsa04380;hsa04620;hsa04630;hsa04917;hsa04919;hsa04933;hsa05140;hsa05145;hsa05152;hsa05160;hsa05161;hsa05162;hsa05164;hsa05168;hsa05200;hsa05212;hsa05321,,STAT1,,,,,
NM_000937.2:3775,NS_Hs_CART_v1.0,POLR2A,mRNA,1,Housekeeping,,,,,POLR2A,,,,,
NM_001098210.1:1815,NS_Hs_CART_v1.0,CTNNB1,mRNA,0,,,Phenotype;Persistence;Exhaustion;Wnt signaling;T-cell migration;Apoptosis,hsa04015;hsa04310;hsa04390;hsa04510;hsa04520;hsa04530;hsa04550;hsa04670;hsa04916;hsa04919;hsa05100;hsa05130;hsa05166;hsa05200;hsa05205;hsa05210;hsa05213;hsa05215;hsa05216;hsa05217,,CTNNB1,,,,,
NM_005902.3:4220,NS_Hs_CART_v1.0,SMAD3,mRNA,0,,,Phenotype;Metabolism;Wnt signaling;Treg;Th9;Th17;TGF-beta;Notch;Cell Cycle,hsa04068;hsa04110;hsa04144;hsa04310;hsa04350;hsa04390;hsa04520;hsa04550;hsa04933;hsa05142;hsa05161;hsa05166;hsa05200;hsa05210;hsa05212;hsa05220;hsa05321,,SMAD3,,,,,
NM_006140.3:660,NS_Hs_CART_v1.0,CSF2RA,mRNA,0,,,Toxicity;Activation;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa04640;hsa05200,,CSF2RA,,,,,
NM_005621.1:260,NS_Hs_CART_v1.0,S100A12,mRNA,0,,,Toxicity;Cell Types;Activation;Interleukin Signaling,,Neutrophils,S100A12,,,,,
NM_001307.3:175,NS_Hs_CART_v1.0,CLDN7,mRNA,0,,,Persistence;T-cell migration,hsa04514;hsa04530;hsa04670;hsa05160,,CLDN7,,,,,
NM_001781.1:460,NS_Hs_CART_v1.0,CD69,mRNA,0,,,Phenotype;Activation;Treg;Activation Markers,,,CD69,,,,,
NM_002185.2:1610,NS_Hs_CART_v1.0,IL7R,mRNA,0,,,Toxicity;Activation;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04068;hsa04151;hsa04630;hsa04640;hsa05340,,IL7R,,,,,
NM_002287.3:1195,NS_Hs_CART_v1.0,LAIR1,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells,,,LAIR1,,,,,
NM_004131.3:540,NS_Hs_CART_v1.0,GZMB,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Cell Types;Notch;Innate-like T-cells;Cytotoxicity;Apoptosis,hsa04650;hsa04940;hsa05202;hsa05320;hsa05330;hsa05332,Cytotoxic cells,GZMB,,,,,
NM_005041.3:2120,NS_Hs_CART_v1.0,PRF1,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Cell Types;Innate-like T-cells;Cytotoxicity;Apoptosis,hsa04650;hsa04940;hsa05320;hsa05330;hsa05332;hsa05416,Cytotoxic cells,PRF1,,,,,
NM_005214.3:405,NS_Hs_CART_v1.0,CTLA4,mRNA,0,,,Exhaustion;Activation;TCR signaling;T-cell exhaustion markers;Costimulatory Molecules,hsa04514;hsa04660;hsa05320;hsa05323,,CTLA4,,,,,
NM_012092.2:640,NS_Hs_CART_v1.0,ICOS,mRNA,0,,,Exhaustion;Activation;TCR signaling;Costimulatory Molecules,hsa04514;hsa04660;hsa04672;hsa05340,,ICOS,,,,,
NM_016388.2:770,NS_Hs_CART_v1.0,TRAT1,mRNA,0,,,Cell Types,,T-cells,TRAT1,,,,,
NM_002258.2:85,NS_Hs_CART_v1.0,KLRB1,mRNA,0,,,Toxicity;Exhaustion;Cell Types;NKT Receptors;Interactions with Non-lymphoid Cells,hsa05144,Cytotoxic cells,KLRB1,,,,,
NM_007360.1:760,NS_Hs_CART_v1.0,KLRK1,mRNA,0,,,Toxicity;Exhaustion;Cell Types;NKT Receptors;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04650;hsa05144,Cytotoxic cells,KLRK1,,,,,
NM_000675.3:1095,NS_Hs_CART_v1.0,ADORA2A,mRNA,0,,,Exhaustion;Activation;Costimulatory Molecules,hsa04015;hsa04020;hsa04024;hsa04080;hsa04270;hsa05012;hsa05034,,ADORA2A,,,,,
NM_001337.3:1040,NS_Hs_CART_v1.0,CX3CR1,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CX3CR1,,,,,
NM_001504.1:80,NS_Hs_CART_v1.0,CXCR3,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CXCR3,,,,,
NM_001619.2:555,NS_Hs_CART_v1.0,GRK2,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04062;hsa04144;hsa04724;hsa05032,,GRK2,,,,,
NM_001838.2:1610,NS_Hs_CART_v1.0,CCR7,mRNA,0,,,Toxicity;Phenotype;Activation;Naïve Markers;Memory Markers;Chemokine Signaling,hsa04060;hsa04062;hsa05202,,CCR7,,,,,
NM_002070.2:1000,NS_Hs_CART_v1.0,GNAI2,mRNA,0,,,Persistence;T-cell migration,hsa04015;hsa04022;hsa04024;hsa04062;hsa04071;hsa04261;hsa04360;hsa04530;hsa04540;hsa04611;hsa04670;hsa04713;hsa04723;hsa04724;hsa04725;hsa04726;hsa04727;hsa04728;hsa04730;hsa04914;hsa04915;hsa04916;hsa04921;hsa04923;hsa04924;hsa04971;hsa05012;hsa05030;hsa05032;hsa05034;hsa05133;hsa05142;hsa05145;hsa05200,,GNAI2,,,,,
NM_003467.2:1335,NS_Hs_CART_v1.0,CXCR4,mRNA,0,,,Toxicity;Persistence;Activation;T-cell migration;Chemokine Signaling,hsa04060;hsa04062;hsa04144;hsa04360;hsa04670;hsa04672;hsa05200,,CXCR4,,,,,
NM_004072.1:770,NS_Hs_CART_v1.0,CMKLR1,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,,,CMKLR1,,,,,
NM_004778.1:1835,NS_Hs_CART_v1.0,PTGDR2,mRNA,0,,,Phenotype;Th2,,,PTGDR2,,,,,
NM_005201.2:245,NS_Hs_CART_v1.0,CCR8,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa05203,,CCR8,,,,,
NM_005767.3:1210,NS_Hs_CART_v1.0,LPAR6,mRNA,0,,,Activation;MAPK and PI3K Signaling,hsa04072;hsa04080;hsa04151;hsa05200,,LPAR6,,,,,
NM_006564.1:95,NS_Hs_CART_v1.0,CXCR6,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CXCR6,,,,,
NM_031409.2:935,NS_Hs_CART_v1.0,CCR6,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCR6,,,,,
NM_001258031.1:570,NS_Hs_CART_v1.0,SERINC4,mRNA,0,,,Metabolism;Glutamine metabolism,,,SERINC4,,,,,
NM_006623.2:505,NS_Hs_CART_v1.0,PHGDH,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00260;hsa01100;hsa01200;hsa01230,,PHGDH,,,,,
NM_000291.2:1030,NS_Hs_CART_v1.0,PGK1,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa01100;hsa01200;hsa01230;hsa04066,,PGK1,,,,,
NM_001024847.1:1760,NS_Hs_CART_v1.0,TGFBR2,mRNA,0,,,Phenotype;Activation;Treg;Th9;Th17;TGF-beta;MAPK and PI3K Signaling,hsa04010;hsa04060;hsa04068;hsa04144;hsa04350;hsa04380;hsa04390;hsa04520;hsa04933;hsa05142;hsa05166;hsa05200;hsa05202;hsa05210;hsa05212;hsa05220,,TGFBR2,,,,,
NM_001040056.1:580,NS_Hs_CART_v1.0,MAPK3,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;TGF-beta;TCR signaling;mTOR;MAPK and PI3K Signaling;Innate-like T-cells;Autophagy;Apoptosis,hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04071;hsa04072;hsa04114;hsa04150;hsa04151;hsa04261;hsa04270;hsa04350;hsa04360;hsa04370;hsa04380;hsa04510;hsa04520;hsa04540;hsa04550;hsa04611;hsa04620;hsa04621;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04713;hsa04720;hsa04722;hsa04723;hsa04724;hsa04725;hsa04726;hsa04730;hsa04810;hsa04910;hsa04912;hsa04914;hsa04915;hsa04916;hsa04917;hsa04919;hsa04921;hsa04930;hsa04933;hsa04960;hsa05010;hsa05020;hsa05034;hsa05131;hsa05132;hsa05133;hsa05140;hsa05142;hsa05145;hsa05152;hsa05160;hsa05161;hsa05164;hsa05200;hsa05203;hsa05205;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05216;hsa05218;hsa05219;hsa05220;hsa05221;hsa05223;hsa05230;hsa05231,,MAPK3,,,,,
NM_001079.3:1175,NS_Hs_CART_v1.0,ZAP70,mRNA,0,,,Toxicity;Activation;TCR signaling;NF-kB;Cytotoxicity,hsa04014;hsa04064;hsa04650;hsa04660;hsa05340,,ZAP70,,,,,
NM_001616.3:1245,NS_Hs_CART_v1.0,ACVR2A,mRNA,0,,,Phenotype;TGF-beta,hsa04060;hsa04350;hsa04550,,ACVR2A,,,,,
NM_001715.2:990,NS_Hs_CART_v1.0,BLK,mRNA,0,,,Cell Types,,B-cells,BLK,,,,,
NM_002037.3:765,NS_Hs_CART_v1.0,FYN,mRNA,0,,,Toxicity;Activation;TCR signaling;Cytotoxicity,hsa04071;hsa04072;hsa04360;hsa04380;hsa04510;hsa04520;hsa04611;hsa04650;hsa04660;hsa04664;hsa04725;hsa05020;hsa05130;hsa05162;hsa05416,,FYN,,,,,
NM_002227.1:285,NS_Hs_CART_v1.0,JAK1,mRNA,0,,,Toxicity;Phenotype;Activation;Type II interferon signaling;Type I interferon signaling;Treg;Th17;Th1;MAPK and PI3K Signaling;JAK-STAT,hsa04151;hsa04380;hsa04550;hsa04630;hsa05140;hsa05145;hsa05152;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05168;hsa05169;hsa05200;hsa05203;hsa05212,,JAK1,,,,,
NM_002610.3:1170,NS_Hs_CART_v1.0,PDK1,mRNA,0,,,Phenotype;Metabolism;Vitamin A (RA) signaling;Oxidative phosphorylation,hsa04066;hsa05230,,PDK1,,,,,
NM_002969.3:425,NS_Hs_CART_v1.0,MAPK12,mRNA,0,,,Phenotype;Persistence;Metabolism;Activation;Th17;TCR signaling;T-cell migration;Mitochondrial biogenesis;MAPK and PI3K Signaling;Innate-like T-cells,hsa04010;hsa04015;hsa04068;hsa04071;hsa04114;hsa04261;hsa04370;hsa04380;hsa04550;hsa04611;hsa04620;hsa04621;hsa04622;hsa04660;hsa04664;hsa04668;hsa04670;hsa04722;hsa04723;hsa04728;hsa04750;hsa04912;hsa04914;hsa04917;hsa04933;hsa05014;hsa05120;hsa05131;hsa05132;hsa05133;hsa05140;hsa05142;hsa05145;hsa05152;hsa05160;hsa05164;hsa05169;hsa05205,,MAPK12,,,,,
NM_004783.2:1020,NS_Hs_CART_v1.0,TAOK2,mRNA,0,,,Activation;MAPK and PI3K Signaling,hsa04010,,TAOK2,,,,,
NM_005391.1:585,NS_Hs_CART_v1.0,PDK3,mRNA,0,,,Phenotype;Metabolism;Vitamin A (RA) signaling;Oxidative phosphorylation,,,PDK3,,,,,
NM_013257.3:565,NS_Hs_CART_v1.0,SGK3,mRNA,0,,,Activation;MAPK and PI3K Signaling,hsa04068;hsa04151,,SGK3,,,,,
NM_014002.2:2470,NS_Hs_CART_v1.0,IKBKE,mRNA,0,,,Phenotype;Innate-like T-cells,hsa04620;hsa04622;hsa04623;hsa05160;hsa05161;hsa05162;hsa05164;hsa05168,,IKBKE,,,,,
NM_145185.2:495,NS_Hs_CART_v1.0,MAP2K7,mRNA,0,,,Phenotype;Activation;TCR signaling;MAPK and PI3K Signaling;Innate-like T-cells,hsa04010;hsa04012;hsa04380;hsa04620;hsa04660;hsa04664;hsa04668;hsa04722;hsa04912;hsa05164;hsa05169,,MAP2K7,,,,,
NM_145333.1:670,NS_Hs_CART_v1.0,MAP3K7,mRNA,0,,,Toxicity;Phenotype;Metabolism;Activation;Wnt signaling;TCR signaling;NF-kB;MAPK and PI3K Signaling;Innate-like T-cells;Autophagy,hsa04010;hsa04064;hsa04152;hsa04310;hsa04380;hsa04520;hsa04620;hsa04621;hsa04622;hsa04660;hsa04668;hsa05140;hsa05145;hsa05162;hsa05168;hsa05169,,MAP3K7,,,,,
NM_173354.2:3240,NS_Hs_CART_v1.0,SIK1,mRNA,0,,,Metabolism;Circadian Clock,hsa04922,,SIK1,,,,,
NM_212535.1:1750,NS_Hs_CART_v1.0,PRKCB,mRNA,0,,,Toxicity;Phenotype;Persistence;Metabolism;Activation;Wnt signaling;T-cell migration;NF-kB;mTOR;MAPK and PI3K Signaling;Cell Cycle,hsa04010;hsa04012;hsa04014;hsa04015;hsa04020;hsa04062;hsa04064;hsa04066;hsa04070;hsa04071;hsa04150;hsa04270;hsa04310;hsa04370;hsa04510;hsa04530;hsa04540;hsa04650;hsa04662;hsa04666;hsa04670;hsa04713;hsa04720;hsa04723;hsa04724;hsa04725;hsa04726;hsa04727;hsa04728;hsa04730;hsa04750;hsa04911;hsa04912;hsa04916;hsa04919;hsa04921;hsa04925;hsa04931;hsa04933;hsa04960;hsa04970;hsa04971;hsa04972;hsa04973;hsa05031;hsa05032;hsa05140;hsa05143;hsa05146;hsa05161;hsa05164;hsa05200;hsa05205;hsa05206;hsa05214;hsa05223;hsa05231,,PRKCB,,,,,
NM_000455.4:2060,NS_Hs_CART_v1.0,STK11,mRNA,0,,,Metabolism;Activation;mTOR;MAPK and PI3K Signaling;Autophagy,hsa04068;hsa04150;hsa04151;hsa04152;hsa04211;hsa04920,,STK11,,,,,
NM_000733.2:75,NS_Hs_CART_v1.0,CD3E,mRNA,0,,,Exhaustion;Cell Types;Activation;TCR signaling;Interactions with Non-lymphoid Cells,hsa04640;hsa04660;hsa05142;hsa05162;hsa05166;hsa05340,T-cells,CD3E,,,,,
NM_005442.2:1670,NS_Hs_CART_v1.0,EOMES,mRNA,0,,,Phenotype;Exhaustion;Cell Types;T-cell exhaustion markers;Innate-like T-cells,,Exhausted CD8,EOMES,,,,,
NM_006144.2:155,NS_Hs_CART_v1.0,GZMA,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Cell Types;Innate-like T-cells;Cytotoxicity;Apoptosis,hsa04080,Cytotoxic cells,GZMA,,,,,
NM_152866.2:620,NS_Hs_CART_v1.0,MS4A1,mRNA,0,,,Cell Types,hsa04640,B-cells,MS4A1,,,,,
NM_182907.1:310,NS_Hs_CART_v1.0,PRDM1,mRNA,0,,,Phenotype;Treg,,,PRDM1,,,,,
NM_002166.4:505,NS_Hs_CART_v1.0,ID2,mRNA,0,,,Phenotype;TGF-beta;Innate-like T-cells,hsa04350;hsa04390;hsa04550;hsa05202,,ID2,,,,,
NM_001251.2:1140,NS_Hs_CART_v1.0,CD68,mRNA,0,,,Cell Types,hsa04142,Macrophages,CD68,,,,,
NM_002417.2:4020,NS_Hs_CART_v1.0,MKI67,mRNA,0,,,Metabolism;Cell Cycle,,,MKI67,,,,,
NM_004563.2:795,NS_Hs_CART_v1.0,PCK2,mRNA,0,,,Metabolism;Activation;MAPK and PI3K Signaling;Glycolysis,hsa00010;hsa00020;hsa00620;hsa01100;hsa03320;hsa04068;hsa04151;hsa04152;hsa04910;hsa04920;hsa04922;hsa04931,,PCK2,,,,,
NM_172037.2:505,NS_Hs_CART_v1.0,RDH10,mRNA,0,,,Phenotype;Vitamin A (RA) signaling,hsa01100,,RDH10,,,,,
NM_002647.2:1140,NS_Hs_CART_v1.0,PIK3C3,mRNA,0,,,Metabolism;Autophagy,hsa01100;hsa04070;hsa04140;hsa04145;hsa05152,,PIK3C3,,,,,
NM_002660.2:2290,NS_Hs_CART_v1.0,PLCG1,mRNA,0,,,Toxicity;Persistence;Activation;TCR signaling;T-cell migration;NF-kB,hsa01100;hsa04012;hsa04014;hsa04015;hsa04020;hsa04064;hsa04066;hsa04070;hsa04072;hsa04370;hsa04650;hsa04660;hsa04664;hsa04666;hsa04670;hsa04722;hsa04750;hsa04919;hsa04933;hsa05120;hsa05169;hsa05200;hsa05205;hsa05206;hsa05214;hsa05223;hsa05231,,PLCG1,,,,,
NM_000175.2:1695,NS_Hs_CART_v1.0,GPI,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00030;hsa01100;hsa01200,,GPI,,,,,
NM_138554.2:2570,NS_Hs_CART_v1.0,TLR4,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Activation;NF-kB;MAPK and PI3K Signaling;Innate-like T-cells;Apoptosis;Antigen processing & presentation,hsa04064;hsa04066;hsa04145;hsa04151;hsa04620;hsa05130;hsa05132;hsa05133;hsa05134;hsa05140;hsa05142;hsa05144;hsa05145;hsa05146;hsa05152;hsa05161;hsa05162;hsa05164;hsa05205;hsa05321;hsa05323,,TLR4,,,,,
NM_000615.5:1620,NS_Hs_CART_v1.0,NCAM1,mRNA,0,,,Toxicity;Type II interferon signaling,hsa04514;hsa05020,,NCAM1,,,,,
NM_004577.3:225,NS_Hs_CART_v1.0,PSPH,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00260;hsa01100;hsa01200;hsa01230,,PSPH,,,,,
NM_021154.3:1445,NS_Hs_CART_v1.0,PSAT1,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00260;hsa01100;hsa01200;hsa01230,,PSAT1,,,,,
NM_006474.4:431,NS_Hs_CART_v1.0,PDPN,mRNA,0,,,Exhaustion;T-cell exhaustion markers,,,PDPN,,,,,
NM_001079874.1:352,NS_Hs_CART_v1.0,VAV3,mRNA,0,,,Toxicity;Persistence;Activation;TCR signaling;T-cell migration;Cytotoxicity,hsa04024;hsa04062;hsa04510;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04670;hsa04810,,VAV3,,,,,
NM_001306.3:606,NS_Hs_CART_v1.0,CLDN3,mRNA,0,,,Persistence;T-cell migration,hsa04514;hsa04530;hsa04670;hsa05160,,CLDN3,,,,,
NM_004104.4:5387,NS_Hs_CART_v1.0,FASN,mRNA,0,,,Metabolism;Activation;Myc targets;Lipid Metabolism,hsa00061;hsa01100;hsa01212;hsa04152;hsa04910,,FASN,,,,,
NM_000962.2:700,NS_Hs_CART_v1.0,PTGS1,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa01100;hsa04611;hsa04726;hsa04923,,PTGS1,,,,,
NM_001031683.2:1470,NS_Hs_CART_v1.0,IFIT3,mRNA,0,,,Toxicity;Type I interferon signaling,,,IFIT3,,,,,
NM_001192.2:635,NS_Hs_CART_v1.0,TNFRSF17,mRNA,0,,,Cell Types,hsa04060;hsa04672,B-cells,TNFRSF17,,,,,
NM_001335.3:1075,NS_Hs_CART_v1.0,CTSW,mRNA,0,,,Exhaustion;Cell Types;Apoptosis,hsa04142,Cytotoxic cells,CTSW,,,,,
NM_001547.4:1995,NS_Hs_CART_v1.0,IFIT2,mRNA,0,,,Toxicity;Type I interferon signaling,,,IFIT2,,,,,
NM_001548.3:1440,NS_Hs_CART_v1.0,IFIT1,mRNA,0,,,Toxicity;Type I interferon signaling,hsa05160;hsa05168,,IFIT1,,,,,
NM_001768.5:1320,NS_Hs_CART_v1.0,CD8A,mRNA,0,,,Exhaustion;Cell Types;Activation;TCR signaling;Interactions with Non-lymphoid Cells,hsa04514;hsa04612;hsa04640;hsa04660;hsa05340,CD8 T cells,CD8A,,,,,
NM_002286.5:1735,NS_Hs_CART_v1.0,LAG3,mRNA,0,,,Exhaustion;Cell Types;Activation;T-cell exhaustion markers;Costimulatory Molecules;Antigen processing & presentation,,Exhausted CD8,LAG3,,,,,
NM_002294.2:380,NS_Hs_CART_v1.0,LAMP2,mRNA,0,,,Metabolism;Autophagy,hsa04142;hsa04145;hsa05152,,LAMP2,,,,,
NM_002994.3:250,NS_Hs_CART_v1.0,CXCL5,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04668;hsa05133;hsa05323,,CXCL5,,,,,
NM_005101.3:305,NS_Hs_CART_v1.0,ISG15,mRNA,0,,,Toxicity;Type I interferon signaling,hsa04622,,ISG15,,,,,
NM_005533.3:415,NS_Hs_CART_v1.0,IFI35,mRNA,0,,,Toxicity;Type I interferon signaling,,,IFI35,,,,,
NM_005956.2:2675,NS_Hs_CART_v1.0,MTHFD1,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00670;hsa01100,,MTHFD1,,,,,
NM_016269.3:1165,NS_Hs_CART_v1.0,LEF1,mRNA,0,,,Phenotype;Wnt signaling,hsa04310;hsa04390;hsa04520;hsa04916;hsa05200;hsa05210;hsa05213;hsa05215;hsa05216;hsa05217;hsa05221,,LEF1,,,,,
NM_033423.3:705,NS_Hs_CART_v1.0,GZMH,mRNA,0,,,Toxicity;Exhaustion;Cell Types;Cytotoxicity;Apoptosis,,Cytotoxic cells,GZMH,,,,,
NM_198213.1:260,NS_Hs_CART_v1.0,OASL,mRNA,0,,,Toxicity;Type II interferon signaling;Type I interferon signaling,,,OASL,,,,,
NM_005317.2:669,NS_Hs_CART_v1.0,GZMM,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Innate-like T-cells;Cytotoxicity;Apoptosis,,,GZMM,,,,,
NM_005601.3:632,NS_Hs_CART_v1.0,NKG7,mRNA,0,,,Cell Types,,Cytotoxic cells,NKG7,,,,,
NM_005623.2:689,NS_Hs_CART_v1.0,CCL8,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL8,,,,,
NM_004152.2:313,NS_Hs_CART_v1.0,OAZ1,mRNA,1,Housekeeping,,,,,OAZ1,,,,,
NM_001010915.3:416,NS_Hs_CART_v1.0,HACD4,mRNA,0,,,Metabolism;Lipid Metabolism,hsa01212,,HACD4,,,,,
NM_013289.2:1626,NS_Hs_CART_v1.0,KIR3DL1/2,mRNA,0,,,Toxicity;Exhaustion;Cell Types;NKT Receptors;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04612;hsa04650;hsa05332,NK CD56dim cells,KIR3DL1,,,,,
NM_001111.3:6091,NS_Hs_CART_v1.0,ADAR,mRNA,0,,,Toxicity;Type I interferon signaling,hsa04623;hsa05162;hsa05164,,ADAR,,,,,
NM_001766.3:1428,NS_Hs_CART_v1.0,CD1D,mRNA,0,,,Phenotype;Exhaustion;Interactions with Non-lymphoid Cells;Innate-like T-cells,hsa04640;hsa05146,,CD1D,,,,,
NM_002163.2:253,NS_Hs_CART_v1.0,IRF8,mRNA,0,,,Toxicity;Phenotype;Type II interferon signaling;Type I interferon signaling;Th17,hsa05133,,IRF8,,,,,
NM_003151.2:789,NS_Hs_CART_v1.0,STAT4,mRNA,0,,,Phenotype;Activation;Th1;JAK-STAT,hsa04630;hsa05161;hsa05321,,STAT4,,,,,
NM_003254.2:329,NS_Hs_CART_v1.0,TIMP1,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,hsa04066,,TIMP1,,,,,
NM_004417.2:987,NS_Hs_CART_v1.0,DUSP1,mRNA,0,,,Activation;Myc targets;MAPK and PI3K Signaling,hsa04010;hsa04726,,DUSP1,,,,,
NM_005534.3:799,NS_Hs_CART_v1.0,IFNGR2,mRNA,0,,,Toxicity;Phenotype;Activation;Type II interferon signaling;Th1;JAK-STAT;Cytotoxicity,hsa04060;hsa04066;hsa04380;hsa04630;hsa04650;hsa05132;hsa05140;hsa05142;hsa05145;hsa05152;hsa05162;hsa05164;hsa05168;hsa05321,,IFNGR2,,,,,
NM_006273.2:120,NS_Hs_CART_v1.0,CCL7,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL7,,,,,
NM_005953.3:225,NS_Hs_CART_v1.0,MT2A,mRNA,0,,,Toxicity;Metabolism;Type II interferon signaling;Mitochondrial biogenesis,,,MT2A,,,,,
NM_005399.3:1600,NS_Hs_CART_v1.0,PRKAB2,mRNA,0,,,Metabolism;Mitochondrial biogenesis;mTOR;Lipid Metabolism;Circadian Clock;Autophagy,hsa04068;hsa04152;hsa04211;hsa04213;hsa04710;hsa04910;hsa04920;hsa04921;hsa04922;hsa04931;hsa04932,,PRKAB2,,,,,
NM_024996.5:1610,NS_Hs_CART_v1.0,GFM1,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,GFM1,,,,,
NM_003811.3:398,NS_Hs_CART_v1.0,TNFSF9,mRNA,0,,,Exhaustion;Activation;T-cell exhaustion markers;Costimulatory Molecules,hsa04060,,TNFSF9,,,,,
NM_000214.2:915,NS_Hs_CART_v1.0,JAG1,mRNA,0,,,Phenotype;Th2;Notch,hsa04330;hsa04668,,JAG1,,,,,
NM_003150.3:2060,NS_Hs_CART_v1.0,STAT3,mRNA,0,,,Phenotype;Exhaustion;Activation;Treg;Th17;Tfh;JAK-STAT;Apoptosis,hsa04062;hsa04066;hsa04068;hsa04550;hsa04630;hsa04917;hsa04920;hsa04931;hsa04933;hsa05145;hsa05160;hsa05161;hsa05162;hsa05169;hsa05200;hsa05203;hsa05205;hsa05206;hsa05212;hsa05221;hsa05321,,STAT3,,,,,
NM_006074.3:1745,NS_Hs_CART_v1.0,TRIM22,mRNA,0,,,Toxicity;Type II interferon signaling,,,TRIM22,,,,,
NM_004422.2:1025,NS_Hs_CART_v1.0,DVL2,mRNA,0,,,Phenotype;Metabolism;Wnt signaling;Notch;mTOR,hsa04310;hsa04330;hsa04390;hsa04550;hsa04916;hsa05166;hsa05200;hsa05217,,DVL2,,,,,
NM_000577.3:480,NS_Hs_CART_v1.0,IL1RN,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL1RN,,,,,
NM_181449.1:330,NS_Hs_CART_v1.0,CD300E,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,,,CD300E,,,,,
NM_019111.3:335,NS_Hs_CART_v1.0,HLA-DRA,mRNA,0,,,Toxicity;Activation;Type II interferon signaling;Antigen processing & presentation,hsa04145;hsa04514;hsa04612;hsa04640;hsa04672;hsa04940;hsa05140;hsa05145;hsa05150;hsa05152;hsa05164;hsa05166;hsa05168;hsa05169;hsa05310;hsa05320;hsa05321;hsa05322;hsa05323;hsa05330;hsa05332;hsa05416,,HLA-DRA,,,,,
NM_000732.4:110,NS_Hs_CART_v1.0,CD3D,mRNA,0,,,Exhaustion;Cell Types;Activation;TCR signaling;Interactions with Non-lymphoid Cells,hsa04640;hsa04660;hsa05142;hsa05162;hsa05166;hsa05340,T-cells,CD3D,,,,,
NM_000632.3:515,NS_Hs_CART_v1.0,ITGAM,mRNA,0,,,Persistence;T-cell migration,hsa04015;hsa04145;hsa04514;hsa04640;hsa04670;hsa04810;hsa05133;hsa05134;hsa05140;hsa05146;hsa05150;hsa05152;hsa05202,,ITGAM,,,,,
NM_001763.2:1815,NS_Hs_CART_v1.0,CD1A,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa04640,,CD1A,,,,,
NM_001769.2:405,NS_Hs_CART_v1.0,CD9,mRNA,0,,,Persistence;T-cell migration,hsa04640,,CD9,,,,,
NM_002183.2:745,NS_Hs_CART_v1.0,IL3RA,mRNA,0,,,Toxicity;Exhaustion;Activation;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling;Apoptosis,hsa04060;hsa04151;hsa04210;hsa04630;hsa04640,,IL3RA,,,,,
NM_006137.6:440,NS_Hs_CART_v1.0,CD7,mRNA,0,,,Metabolism;Cell Cycle,hsa04640,,CD7,,,,,
NM_001771.2:2515,NS_Hs_CART_v1.0,CD22,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa04514;hsa04640;hsa04662,,CD22,,,,,
NM_080921.2:90,NS_Hs_CART_v1.0,PTPRC,mRNA,0,,NM_002838.4:258;NM_080921.3:258,Cell Types;Activation;TCR signaling,hsa04514;hsa04660;hsa04666;hsa05340,CD45,PTPRC,,,,,
NM_014261.1:518,NS_Hs_CART_v1.0,TICAM1,mRNA,0,,,Toxicity;Phenotype;Exhaustion;NF-kB;Innate-like T-cells;Apoptosis,hsa04064;hsa04620;hsa05133;hsa05142;hsa05160;hsa05161;hsa05164;hsa05168,,TICAM1,,,,,
NM_001102.3:2760,NS_Hs_CART_v1.0,ACTN1,mRNA,0,,,Persistence;T-cell migration,hsa04510;hsa04520;hsa04530;hsa04670;hsa04810;hsa05146;hsa05203;hsa05322,,ACTN1,,,,,
NM_005165.2:260,NS_Hs_CART_v1.0,ALDOC,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00030;hsa00051;hsa01100;hsa01200;hsa01230,,ALDOC,,,,,
NM_004244.4:1630,NS_Hs_CART_v1.0,CD163,mRNA,0,,,Cell Types,,Macrophages,CD163,,,,,
NM_006636.3:1005,NS_Hs_CART_v1.0,MTHFD2,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00670;hsa01100,,MTHFD2,,,,,
NM_000269.2:500,NS_Hs_CART_v1.0,NME1,mRNA,0,,,Activation;Myc targets,hsa00230;hsa01100,,NME1,,,,,
NM_182471.1:2105,NS_Hs_CART_v1.0,PKM,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00230;hsa00620;hsa01100;hsa01200;hsa01230;hsa04922;hsa04930;hsa05203;hsa05230,,PKM,,,,,
NM_024330.1:1740,NS_Hs_CART_v1.0,SLC27A3,mRNA,0,,,Metabolism;Lipid Metabolism,hsa04931,,SLC27A3,,,,,
NM_002791.1:901,NS_Hs_CART_v1.0,PSMA6,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;Wnt signaling;Notch;Cell Cycle;Apoptosis;Antigen processing & presentation,hsa03050,,PSMA6,,,,,
NM_000591.2:885,NS_Hs_CART_v1.0,CD14,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Activation;NF-kB;MAPK and PI3K Signaling;Innate-like T-cells;Apoptosis;Antigen processing & presentation,hsa04010;hsa04064;hsa04145;hsa04620;hsa04640;hsa04810;hsa05130;hsa05132;hsa05133;hsa05134;hsa05146;hsa05152;hsa05202,,CD14,,,,,
NM_014009.3:1230,NS_Hs_CART_v1.0,FOXP3,mRNA,0,,,Phenotype;Cell Types;Treg;Th17,hsa05321,Treg,FOXP3,,,,,
NM_001562.2:48,NS_Hs_CART_v1.0,IL18,mRNA,0,,,Toxicity;Phenotype;Activation;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04621;hsa04623;hsa05132;hsa05134;hsa05143;hsa05144;hsa05152;hsa05164;hsa05321;hsa05323,,IL18,,,,,
NM_000206.1:595,NS_Hs_CART_v1.0,IL2RG,mRNA,0,,,Toxicity;Phenotype;Activation;Th2;Th17;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04144;hsa04151;hsa04630;hsa05162;hsa05166;hsa05321;hsa05340,,IL2RG,,,,,
NM_006516.2:2500,NS_Hs_CART_v1.0,SLC2A1,mRNA,0,,,Metabolism;Glycolysis,hsa04066;hsa04911;hsa04919;hsa04920;hsa04922;hsa04931;hsa05166;hsa05200;hsa05211;hsa05230,,SLC2A1,,,,,
NM_134261.2:1715,NS_Hs_CART_v1.0,RORA,mRNA,0,,,Phenotype;Metabolism;Th17;Innate-like T-cells;Circadian Clock,hsa04710;hsa05321,,RORA,,,,,
NM_001558.2:150,NS_Hs_CART_v1.0,IL10RA,mRNA,0,,,Toxicity;Phenotype;Activation;Treg;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa05145;hsa05152;hsa05169,,IL10RA,,,,,
NM_000878.2:1980,NS_Hs_CART_v1.0,IL2RB,mRNA,0,,,Toxicity;Phenotype;Activation;Th2;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04144;hsa04151;hsa04630;hsa05162;hsa05166;hsa05202,,IL2RB,,,,,
NM_006907.2:513,NS_Hs_CART_v1.0,PYCR1,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00330;hsa01100;hsa01230,,PYCR1,,,,,
NM_002989.2:180,NS_Hs_CART_v1.0,CCL21,mRNA,0,,,Toxicity;Activation;NF-kB;Chemokine Signaling,hsa04060;hsa04062;hsa04064,,CCL21,,,,,
NM_001712.3:2455,NS_Hs_CART_v1.0,CEACAM1,mRNA,0,,,Toxicity;NKT Receptors,,,CEACAM1,,,,,
NM_002184.2:2505,NS_Hs_CART_v1.0,IL6ST,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;JAK-STAT;Interleukin Signaling,hsa04060;hsa04550;hsa04630;hsa05203,,IL6ST,,,,,
NM_005005.2:80,NS_Hs_CART_v1.0,NDUFB9,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04932;hsa05010;hsa05012;hsa05016,,NDUFB9,,,,,
NM_052902.2:565,NS_Hs_CART_v1.0,STK11IP,mRNA,1,Housekeeping,,,,,STK11IP,,,,,
NM_015527.3:2915,NS_Hs_CART_v1.0,TBC1D10B,mRNA,1,Housekeeping,,,,,TBC1D10B,,,,,
NM_001964.2:1505,NS_Hs_CART_v1.0,EGR1,mRNA,0,,,Toxicity;Type I interferon signaling,hsa04933;hsa05020;hsa05166,,EGR1,,,,,
NM_000143.2:203,NS_Hs_CART_v1.0,FH,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00020;hsa00620;hsa01100;hsa01200;hsa05200;hsa05211,,FH,,,,,
NM_000377.2:90,NS_Hs_CART_v1.0,WAS,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04062;hsa04144;hsa04520;hsa04666;hsa04810;hsa05100;hsa05130;hsa05131;hsa05132;hsa05231,,WAS,,,,,
NM_003000.2:245,NS_Hs_CART_v1.0,SDHB,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00020;hsa00190;hsa01100;hsa01200;hsa04932;hsa05010;hsa05012;hsa05016,,SDHB,,,,,
NM_003292.2:6825,NS_Hs_CART_v1.0,TPR,mRNA,0,,,Metabolism;Glycolysis;Cell Cycle,hsa05200;hsa05216,,TPR,,,,,
NM_004374.2:69,NS_Hs_CART_v1.0,COX6C,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,COX6C,,,,,
NM_007331.1:1260,NS_Hs_CART_v1.0,NSD2,mRNA,0,,,Metabolism;Cell Cycle,hsa05202,,NSD2,,,,,
NM_001511.1:742,NS_Hs_CART_v1.0,CXCL1,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04621;hsa04668;hsa05120;hsa05132;hsa05134;hsa05146;hsa05323,,CXCL1,,,,,
NM_002089.3:854,NS_Hs_CART_v1.0,CXCL2,mRNA,0,,,Toxicity;Activation;NF-kB;Chemokine Signaling,hsa04060;hsa04062;hsa04064;hsa04621;hsa04668;hsa05132;hsa05134,,CXCL2,,,,,
NM_000565.2:993,NS_Hs_CART_v1.0,IL6R,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;Tfh;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04066;hsa04151;hsa04630;hsa04640;hsa04932,,IL6R,,,,,
NM_000340.1:3180,NS_Hs_CART_v1.0,SLC2A2,mRNA,0,,,Metabolism;Glycolysis,hsa04911;hsa04917;hsa04922;hsa04930;hsa04931;hsa04973;hsa05230,,SLC2A2,,,,,
NM_000442.3:1365,NS_Hs_CART_v1.0,PECAM1,mRNA,0,,,Phenotype;Persistence;T-cell migration;Naïve Markers,hsa04514;hsa04670;hsa05144,,PECAM1,,,,,
NM_000882.2:775,NS_Hs_CART_v1.0,IL12A,mRNA,0,,,Toxicity;Phenotype;Activation;Th1;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04620;hsa04622;hsa04630;hsa04940;hsa05133;hsa05134;hsa05140;hsa05142;hsa05143;hsa05144;hsa05145;hsa05146;hsa05152;hsa05162;hsa05164;hsa05168;hsa05321;hsa05330,,IL12A,,,,,
NM_000965.3:2755,NS_Hs_CART_v1.0,RARB,mRNA,0,,,Phenotype;Vitamin A (RA) signaling,hsa05200;hsa05222;hsa05223,,RARB,,,,,
NM_002187.2:1435,NS_Hs_CART_v1.0,IL12B,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;Th1;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04620;hsa04622;hsa04630;hsa04940;hsa05133;hsa05134;hsa05140;hsa05142;hsa05143;hsa05145;hsa05146;hsa05152;hsa05162;hsa05164;hsa05168;hsa05205;hsa05321;hsa05330,,IL12B,,,,,
NM_005618.3:2580,NS_Hs_CART_v1.0,DLL1,mRNA,0,,,Phenotype;Th1;Notch,hsa04330,,DLL1,,,,,
NM_006147.2:1430,NS_Hs_CART_v1.0,IRF6,mRNA,0,,,Toxicity;Type II interferon signaling;Type I interferon signaling,,,IRF6,,,,,
NM_013261.3:1505,NS_Hs_CART_v1.0,PPARGC1A,mRNA,0,,,Metabolism;Mitochondrial biogenesis;Circadian Clock,hsa04152;hsa04211;hsa04910;hsa04920;hsa04922;hsa04931;hsa05016,,PPARGC1A,,,,,
NM_020997.2:1405,NS_Hs_CART_v1.0,LEFTY1,mRNA,0,,,Phenotype;TGF-beta,hsa04350,,LEFTY1,,,,,
NM_021101.3:410,NS_Hs_CART_v1.0,CLDN1,mRNA,0,,,Persistence;T-cell migration,hsa04514;hsa04530;hsa04670;hsa05130;hsa05160,,CLDN1,,,,,
NM_001657.2:547,NS_Hs_CART_v1.0,AREG,mRNA,0,,,Phenotype;Activation;MAPK and PI3K Signaling;Innate-like T-cells,hsa04012;hsa04390,,AREG,,,,,
NM_002986.2:378,NS_Hs_CART_v1.0,CCL11,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa05310,,CCL11,,,,,
NM_002526.2:1214,NS_Hs_CART_v1.0,NT5E,mRNA,0,,,Phenotype;Treg,hsa00230;hsa01100,,NT5E,,,,,
NM_003294.3:579,NS_Hs_CART_v1.0,TPSAB1/B2,mRNA,0,,,Cell Types,,Mast cells,TPSAB1,,,,,
NM_002988.2:585,NS_Hs_CART_v1.0,CCL18,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL18,,,,,
NM_001618.3:3016,NS_Hs_CART_v1.0,PARP1,mRNA,0,,,Toxicity;Phenotype;Exhaustion;TGF-beta;NF-kB;Apoptosis,hsa04064,,PARP1,,,,,
NM_145886.2:2133,NS_Hs_CART_v1.0,PIDD1,mRNA,0,,,Toxicity;Exhaustion;NF-kB;Apoptosis,hsa04064;hsa04115,,PIDD1,,,,,
NM_013328.2:1250,NS_Hs_CART_v1.0,PYCR2,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00330;hsa01100;hsa01230,,PYCR2,,,,,
NM_020755.2:95,NS_Hs_CART_v1.0,SERINC1,mRNA,0,,,Metabolism;Glutamine metabolism,,,SERINC1,,,,,
NM_007111.4:1826,NS_Hs_CART_v1.0,TFDP1,mRNA,0,,,Phenotype;Metabolism;Exhaustion;TGF-beta;Notch;Cell Cycle;Apoptosis,hsa04110;hsa04350,,TFDP1,,,,,
NM_002991.2:18,NS_Hs_CART_v1.0,CCL24,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL24,,,,,
NM_005003.2:490,NS_Hs_CART_v1.0,NDUFAB1,mRNA,0,,,Metabolism;Oxidative phosphorylation;Lipid Metabolism,hsa00190;hsa01100;hsa04932;hsa05010;hsa05012;hsa05016,,NDUFAB1,,,,,
NM_007075.3:1390,NS_Hs_CART_v1.0,WDR45,mRNA,0,,,Metabolism;Autophagy,,,WDR45,,,,,
NM_000978.3:71,NS_Hs_CART_v1.0,RPL23,mRNA,0,,,Activation;Myc targets,,,RPL23,,,,,
NM_002629.2:1037,NS_Hs_CART_v1.0,PGAM1,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00260;hsa01100;hsa01200;hsa01230;hsa04922;hsa05230,,PGAM1,,,,,
NM_001064.2:1235,NS_Hs_CART_v1.0,TKT,mRNA,0,,,Metabolism;Glycolysis,hsa00030;hsa01100;hsa01200;hsa01230,,TKT,,,,,
NM_006888.3:1683,NS_Hs_CART_v1.0,CALM1,mRNA,0,,,Phenotype;Metabolism;Activation;Wnt signaling;NFAT;Mitochondrial biogenesis,hsa04014;hsa04015;hsa04020;hsa04022;hsa04024;hsa04070;hsa04114;hsa04261;hsa04270;hsa04713;hsa04720;hsa04722;hsa04728;hsa04750;hsa04910;hsa04912;hsa04915;hsa04916;hsa04921;hsa04922;hsa04924;hsa04925;hsa04970;hsa04971;hsa05010;hsa05031;hsa05034;hsa05133;hsa05152;hsa05214,,CALM1,,,,,
NM_001572.3:1763,NS_Hs_CART_v1.0,IRF7,mRNA,0,,,Toxicity;Phenotype;Type II interferon signaling;Type I interferon signaling;Innate-like T-cells,hsa04620;hsa04622;hsa04623;hsa05160;hsa05161;hsa05162;hsa05164;hsa05168;hsa05203,,IRF7,,,,,
NM_000064.2:4396,NS_Hs_CART_v1.0,C3,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa04145;hsa05133;hsa05134;hsa05140;hsa05142;hsa05150;hsa05152;hsa05168;hsa05203;hsa05322,,C3,,,,,
NM_000397.3:2686,NS_Hs_CART_v1.0,CYBB,mRNA,0,,,Persistence;Activation;T-cell migration;Antigen processing & presentation,hsa04066;hsa04145;hsa04380;hsa04670;hsa04933,,CYBB,,,,,
NM_001098627.1:2023,NS_Hs_CART_v1.0,IRF5,mRNA,0,,,Toxicity;Phenotype;Type II interferon signaling;Type I interferon signaling;Innate-like T-cells,hsa04620,,IRF5,,,,,
NM_002188.2:516,NS_Hs_CART_v1.0,IL13,mRNA,0,,,Toxicity;Phenotype;Activation;Th2;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04630;hsa04664;hsa05162;hsa05310;hsa05321,,IL13,,,,,
NM_004513.4:1262,NS_Hs_CART_v1.0,IL16,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL16,,,,,
NM_005082.4:3414,NS_Hs_CART_v1.0,TRIM25,mRNA,0,,,Toxicity;Type II interferon signaling;NF-kB,hsa04064;hsa04622;hsa05164,,TRIM25,,,,,
NM_005190.3:744,NS_Hs_CART_v1.0,CCNC,mRNA,0,,,Phenotype;TGF-beta;Notch,,,CCNC,,,,,
NM_014248.2:162,NS_Hs_CART_v1.0,RBX1,mRNA,0,,,Phenotype;Metabolism;Activation;Wnt signaling;TGF-beta;Notch;Circadian Clock;Cell Cycle;Antigen processing & presentation,hsa04066;hsa04110;hsa04114;hsa04120;hsa04310;hsa04350;hsa04710;hsa05200;hsa05211,,RBX1,,,,,
NM_019009.2:1320,NS_Hs_CART_v1.0,TOLLIP,mRNA,0,,,Phenotype;Innate-like T-cells,hsa04620,,TOLLIP,,,,,
NM_020525.4:319,NS_Hs_CART_v1.0,IL22,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04630;hsa05321,,IL22,,,,,
NM_021242.4:852,NS_Hs_CART_v1.0,MID1IP1,mRNA,0,,,Metabolism;Lipid Metabolism,,,MID1IP1,,,,,
NM_148672.2:407,NS_Hs_CART_v1.0,CCL28,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04672,,CCL28,,,,,
NM_005516.4:1204,NS_Hs_CART_v1.0,HLA-E,mRNA,0,,,Toxicity;Exhaustion;Activation;Type II interferon signaling;Type I interferon signaling;Interactions with Non-lymphoid Cells;Antigen processing & presentation,hsa04144;hsa04145;hsa04514;hsa04612;hsa04650;hsa04940;hsa05166;hsa05168;hsa05169;hsa05203;hsa05320;hsa05330;hsa05332;hsa05416,,HLA-E,,,,,
NM_002000.2:1415,NS_Hs_CART_v1.0,FCAR,mRNA,0,,,Cell Types,hsa04145;hsa05150,Neutrophils,FCAR,,,,,
NM_002015.3:1526,NS_Hs_CART_v1.0,FOXO1,mRNA,0,,,Phenotype;Treg,hsa04068;hsa04152;hsa04211;hsa04213;hsa04910;hsa04919;hsa04922;hsa04931;hsa04933;hsa05200;hsa05202;hsa05215,,FOXO1,,,,,
NM_005903.5:1044,NS_Hs_CART_v1.0,SMAD5,mRNA,0,,,Phenotype;TGF-beta,hsa04350;hsa04550,,SMAD5,,,,,
NM_181349.1:5162,NS_Hs_CART_v1.0,SMURF1,mRNA,0,,,Phenotype;Metabolism;Activation;Wnt signaling;TGF-beta;Mitochondrial biogenesis;Antigen processing & presentation,hsa04120;hsa04144;hsa04350,,SMURF1,,,,,
NM_002981.1:157,NS_Hs_CART_v1.0,CCL1,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL1,,,,,
NM_005428.2:764,NS_Hs_CART_v1.0,VAV1,mRNA,0,,,Toxicity;Persistence;Activation;TCR signaling;T-cell migration;Cytotoxicity,hsa04024;hsa04062;hsa04510;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04670;hsa04810,,VAV1,,,,,
NM_016584.2:411,NS_Hs_CART_v1.0,IL23A,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04630;hsa05133;hsa05152;hsa05321;hsa05323,,IL23A,,,,,
NM_018724.3:292,NS_Hs_CART_v1.0,IL20,mRNA,0,,,Toxicity;Activation;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630,,IL20,,,,,
NM_006274.2:401,NS_Hs_CART_v1.0,CCL19,mRNA,0,,,Toxicity;Activation;NF-kB;Chemokine Signaling,hsa04060;hsa04062;hsa04064,,CCL19,,,,,
NM_013246.2:1296,NS_Hs_CART_v1.0,CLCF1,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,hsa04060,,CLCF1,,,,,
NM_145659.3:143,NS_Hs_CART_v1.0,IL27,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL27,,,,,
NM_001870.2:220,NS_Hs_CART_v1.0,CPA3,mRNA,0,,,Cell Types,hsa04972,Mast cells,CPA3,,,,,
NM_002990.3:797,NS_Hs_CART_v1.0,CCL22,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL22,,,,,
NM_002993.3:539,NS_Hs_CART_v1.0,CXCL6,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa05133;hsa05323,,CXCL6,,,,,
NM_004590.2:367,NS_Hs_CART_v1.0,CCL16,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL16,,,,,
NM_022789.2:1027,NS_Hs_CART_v1.0,IL25,mRNA,0,,,Toxicity;Phenotype;Activation;Interleukin Signaling;Innate-like T-cells,hsa04060,,IL25,,,,,
NM_002987.2:229,NS_Hs_CART_v1.0,CCL17,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL17,,,,,
NM_006072.4:184,NS_Hs_CART_v1.0,CCL26,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL26,,,,,
NM_005408.2:320,NS_Hs_CART_v1.0,CCL13,mRNA,0,,,Toxicity;Cell Types;Activation;NF-kB;Chemokine Signaling,hsa04060;hsa04062;hsa04064,DC,CCL13,,,,,
NM_000588.3:130,NS_Hs_CART_v1.0,IL3,mRNA,0,,,Toxicity;Exhaustion;Activation;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling;Apoptosis,hsa04060;hsa04151;hsa04210;hsa04630;hsa04640;hsa04664;hsa05202;hsa05310,,IL3,,,,,
NM_000944.4:3920,NS_Hs_CART_v1.0,PPP3CA,mRNA,0,,,Phenotype;Activation;Wnt signaling;TCR signaling;NFAT;MAPK and PI3K Signaling,hsa04010;hsa04020;hsa04022;hsa04114;hsa04210;hsa04310;hsa04360;hsa04370;hsa04380;hsa04650;hsa04660;hsa04662;hsa04720;hsa04724;hsa04728;hsa04921;hsa04922;hsa04924;hsa05010;hsa05014;hsa05031;hsa05152;hsa05166,,PPP3CA,,,,,
NM_001559.2:1315,NS_Hs_CART_v1.0,IL12RB2,mRNA,0,,,Toxicity;Phenotype;Activation;Th1;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa05321,,IL12RB2,,,,,
NM_001909.3:1495,NS_Hs_CART_v1.0,CTSD,mRNA,0,,,Metabolism;Exhaustion;Activation;Autophagy;Apoptosis;Antigen processing & presentation,hsa04071;hsa04142;hsa05152,,CTSD,,,,,
NM_003486.5:785,NS_Hs_CART_v1.0,SLC7A5,mRNA,0,,,Metabolism;mTOR,hsa05230,,SLC7A5,,,,,
NM_006939.2:3845,NS_Hs_CART_v1.0,SOS2,mRNA,0,,,Toxicity;Metabolism;Activation;TCR signaling;mTOR;MAPK and PI3K Signaling;JAK-STAT;Cytotoxicity,hsa04010;hsa04012;hsa04014;hsa04062;hsa04068;hsa04072;hsa04151;hsa04510;hsa04540;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04722;hsa04810;hsa04910;hsa04912;hsa04915;hsa04917;hsa05034;hsa05160;hsa05200;hsa05205;hsa05206;hsa05211;hsa05213;hsa05214;hsa05215;hsa05220;hsa05221;hsa05223;hsa05231,,SOS2,,,,,
NM_014011.4:660,NS_Hs_CART_v1.0,SOCS5,mRNA,0,,,Activation;JAK-STAT,hsa04630;hsa04917,,SOCS5,,,,,
NM_018402.1:80,NS_Hs_CART_v1.0,IL26,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,hsa04060,,IL26,,,,,
NM_018717.4:1350,NS_Hs_CART_v1.0,MAML3,mRNA,0,,,Phenotype;Th1;Notch,hsa04330,,MAML3,,,,,
NM_021803.2:65,NS_Hs_CART_v1.0,IL21,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;Tfh;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa05321,,IL21,,,,,
NM_170679.2:630,NS_Hs_CART_v1.0,SKP1,mRNA,0,,,Phenotype;Metabolism;Activation;Wnt signaling;TGF-beta;Notch;Circadian Clock;Cell Cycle;Antigen processing & presentation,hsa04110;hsa04114;hsa04120;hsa04310;hsa04350;hsa04710;hsa05168,,SKP1,,,,,
NM_000590.1:300,NS_Hs_CART_v1.0,IL9,mRNA,0,,,Toxicity;Phenotype;Activation;Th9;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa05310,,IL9,,,,,
NM_002831.5:1734,NS_Hs_CART_v1.0,PTPN6,mRNA,0,,,Toxicity;Activation;Type II interferon signaling;Type I interferon signaling;TCR signaling;JAK-STAT;Cytotoxicity,hsa04520;hsa04630;hsa04650;hsa04660;hsa04662;hsa05140;hsa05205,,PTPN6,,,,,
NM_145071.2:558,NS_Hs_CART_v1.0,CISH,mRNA,0,,,Activation;JAK-STAT,hsa04630;hsa04917,,CISH,,,,,
NM_001143674.1:285,NS_Hs_CART_v1.0,MPC2,mRNA,0,,,Metabolism;Oxidative phosphorylation;Mitochondrial biogenesis,,,MPC2,,,,,
NM_014865.3:3160,NS_Hs_CART_v1.0,NCAPD2,mRNA,0,,,Metabolism;Cell Cycle,,,NCAPD2,,,,,
NM_004103.3:735,NS_Hs_CART_v1.0,PTK2B,mRNA,0,,,Toxicity;Persistence;T-cell migration;Cytotoxicity,hsa04020;hsa04062;hsa04072;hsa04650;hsa04670;hsa04912;hsa05161,,PTK2B,,,,,
NM_003121.3:1029,NS_Hs_CART_v1.0,SPIB,mRNA,0,,,Phenotype;Cell Types;Th9,,B-cells,SPIB,,,,,
NM_006327.2:685,NS_Hs_CART_v1.0,TIMM23,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,TIMM23,,,,,
NM_006986.3:661,NS_Hs_CART_v1.0,MAGED1,mRNA,0,,,Exhaustion;Apoptosis,hsa04722,,MAGED1,,,,,
NM_198834.1:3681,NS_Hs_CART_v1.0,ACACA,mRNA,0,,,Metabolism;Lipid Metabolism,hsa00061;hsa00620;hsa01100;hsa01212;hsa04152;hsa04910;hsa04922,,ACACA,,,,,
NM_003023.4:4420,NS_Hs_CART_v1.0,SH3BP2,mRNA,0,,,Toxicity;Cytotoxicity,hsa04650,,SH3BP2,,,,,
NM_032965.3:112,NS_Hs_CART_v1.0,CCL15,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL15,,,,,
NM_001024736.1:2120,NS_Hs_CART_v1.0,CD276,mRNA,0,,,Exhaustion;Activation;Costimulatory Molecules,hsa04514,,CD276,,,,,
NM_175862.3:1265,NS_Hs_CART_v1.0,CD86,mRNA,0,,,Phenotype;Exhaustion;Activation;T-cell exhaustion markers;Innate-like T-cells;Costimulatory Molecules,hsa04514;hsa04620;hsa04672;hsa04940;hsa05202;hsa05320;hsa05322;hsa05323;hsa05330;hsa05332;hsa05416,,CD86,,,,,
NM_025239.3:235,NS_Hs_CART_v1.0,PDCD1LG2,mRNA,0,,,Exhaustion;Activation;Costimulatory Molecules,hsa04514,,PDCD1LG2,,,,,
NM_002122.3:261,NS_Hs_CART_v1.0,HLA-DQA1,mRNA,0,,,Toxicity;Activation;Type II interferon signaling;Antigen processing & presentation,hsa04145;hsa04514;hsa04612;hsa04672;hsa04940;hsa05140;hsa05145;hsa05150;hsa05152;hsa05164;hsa05166;hsa05168;hsa05169;hsa05310;hsa05320;hsa05321;hsa05322;hsa05323;hsa05330;hsa05332;hsa05416,,HLA-DQA1,,,,,
NM_199421.1:805,NS_Hs_CART_v1.0,SOCS4,mRNA,0,,,Activation;JAK-STAT,hsa04630;hsa04910;hsa04917;hsa04930,,SOCS4,,,,,
NM_005944.5:665,NS_Hs_CART_v1.0,CD200,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,,,CD200,,,,,
NM_001147.2:1775,NS_Hs_CART_v1.0,ANGPT2,mRNA,0,,,Activation;MAPK and PI3K Signaling,hsa04014;hsa04015;hsa04066;hsa04151,,ANGPT2,,,,,
NM_139018.3:774,NS_Hs_CART_v1.0,CD300LF,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,,,CD300LF,,,,,
NM_001002021.1:2410,NS_Hs_CART_v1.0,PFKL,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00030;hsa00051;hsa01100;hsa01200;hsa01230;hsa04066;hsa04152;hsa04922;hsa05230,,PFKL,,,,,
NM_148918.1:1800,NS_Hs_CART_v1.0,SHMT1,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00260;hsa00630;hsa00670;hsa01100;hsa01200;hsa01230,,SHMT1,,,,,
NM_173799.2:1968,NS_Hs_CART_v1.0,TIGIT,mRNA,0,,,Exhaustion;Activation;T-cell exhaustion markers;Costimulatory Molecules,hsa04514,,TIGIT,,,,,
NM_006245.2:880,NS_Hs_CART_v1.0,PPP2R5D,mRNA,0,,,Phenotype;Metabolism;Activation;Wnt signaling;MAPK and PI3K Signaling;Glycolysis;Cell Cycle,hsa04071;hsa04114;hsa04151;hsa04152;hsa04261;hsa04728,,PPP2R5D,,,,,
NM_130386.2:900,NS_Hs_CART_v1.0,COLEC12,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa04145,,COLEC12,,,,,
NM_001172085.1:587,NS_Hs_CART_v1.0,TBP,mRNA,1,Housekeeping,,,,,TBP,,,,,
NM_001031806.1:890,NS_Hs_CART_v1.0,ALDH3A2,mRNA,0,,,Metabolism;Lipid Metabolism;Glycolysis,hsa00010;hsa00071;hsa00330;hsa00620;hsa01100,,ALDH3A2,,,,,
NM_080678.1:1087,NS_Hs_CART_v1.0,UBE2F,mRNA,0,,,Activation;Antigen processing & presentation,hsa04120,,UBE2F,,,,,
NM_003600.2:405,NS_Hs_CART_v1.0,AURKA,mRNA,0,,,Metabolism;Cell Cycle,hsa04114,,AURKA,,,,,
NM_015341.3:1550,NS_Hs_CART_v1.0,NCAPH,mRNA,0,,,Metabolism;Cell Cycle,,,NCAPH,,,,,
NM_003006.3:2297,NS_Hs_CART_v1.0,SELPLG,mRNA,0,,,Toxicity;NKT Receptors,hsa04514;hsa05150,,SELPLG,,,,,
TCRVB_017.1:164,NS_Hs_CART_v1.0,TRBV6-9,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_032.1:150,NS_Hs_CART_v1.0,TRBV12-3,mRNA,0,,,Exhaustion;TCR Diversity;Interactions with Non-lymphoid Cells,,,,,,,,
TCRVB_023.1:194,NS_Hs_CART_v1.0,TRBV7-8,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_027.1:62,NS_Hs_CART_v1.0,TRBV10-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_014.1:142,NS_Hs_CART_v1.0,TRBV6-5,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_021.1:76,NS_Hs_CART_v1.0,TRBV7-6,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_010.1:206,NS_Hs_CART_v1.0,TRAV8-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_003.1:177,NS_Hs_CART_v1.0,TRAV2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_004.1:6,NS_Hs_CART_v1.0,TRAV3,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_005.1:159,NS_Hs_CART_v1.0,TRAV4,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_006.1:118,NS_Hs_CART_v1.0,TRAV5,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_007.1:183,NS_Hs_CART_v1.0,TRAV6,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_008.1:126,NS_Hs_CART_v1.0,TRAV7,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_009.1:108,NS_Hs_CART_v1.0,TRAV8-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_011.1:49,NS_Hs_CART_v1.0,TRAV8-3,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_015.1:31,NS_Hs_CART_v1.0,TRAV9-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_016.1:164,NS_Hs_CART_v1.0,TRAV10,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_017.1:135,NS_Hs_CART_v1.0,TRAV11,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_022.1:99,NS_Hs_CART_v1.0,TRAV13-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_023.1:232,NS_Hs_CART_v1.0,TRAV14,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_024.1:222,NS_Hs_CART_v1.0,TRAV16,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_025.1:201,NS_Hs_CART_v1.0,TRAV17,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_026.1:198,NS_Hs_CART_v1.0,TRAV18,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_027.1:227,NS_Hs_CART_v1.0,TRAV19,mRNA,0,,,Exhaustion;TCR Diversity;Interactions with Non-lymphoid Cells,,,,,,,,
TCRVA_028.1:136,NS_Hs_CART_v1.0,TRAV20,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_029.1:176,NS_Hs_CART_v1.0,TRAV21,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_030.1:183,NS_Hs_CART_v1.0,TRAV22,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_031.1:159,NS_Hs_CART_v1.0,TRAV23,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_032.1:88,NS_Hs_CART_v1.0,TRAV24,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_033.1:43,NS_Hs_CART_v1.0,TRAV25,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_034.1:106,NS_Hs_CART_v1.0,TRAV26-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_035.1:11,NS_Hs_CART_v1.0,TRAV26-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_036.1:69,NS_Hs_CART_v1.0,TRAV27,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_037.1:193,NS_Hs_CART_v1.0,TRAV29,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_038.1:141,NS_Hs_CART_v1.0,TRAV30,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_039.1:169,NS_Hs_CART_v1.0,TRAV34,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_040.1:216,NS_Hs_CART_v1.0,TRAV35,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_041.1:156,NS_Hs_CART_v1.0,TRAV36,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_044.1:49,NS_Hs_CART_v1.0,TRAV39,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_045.1:6,NS_Hs_CART_v1.0,TRAV40,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_046.1:38,NS_Hs_CART_v1.0,TRAV41,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_001.1:220,NS_Hs_CART_v1.0,TRBV2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_002.1:86,NS_Hs_CART_v1.0,TRBV3-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_006.1:194,NS_Hs_CART_v1.0,TRBV5-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_013.1:181,NS_Hs_CART_v1.0,TRBV6-4,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_025.1:175,NS_Hs_CART_v1.0,TRBV9,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_040.1:195,NS_Hs_CART_v1.0,TRBV19,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_044.1:162,NS_Hs_CART_v1.0,TRBV27,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_045.1:47,NS_Hs_CART_v1.0,TRBV28,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_046.1:190,NS_Hs_CART_v1.0,TRBV29-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_047.1:5,NS_Hs_CART_v1.0,TRBV30,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_001.1:192,NS_Hs_CART_v1.0,TRAV1-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_013.1:206,NS_Hs_CART_v1.0,TRAV8-6,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_014.1:49,NS_Hs_CART_v1.0,TRAV9-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_018.1:140,NS_Hs_CART_v1.0,TRAV12-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_019.1:116,NS_Hs_CART_v1.0,TRAV12-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_020.1:99,NS_Hs_CART_v1.0,TRAV12-3,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_003.1:143,NS_Hs_CART_v1.0,TRBV4-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_010.1:131,NS_Hs_CART_v1.0,TRBV5-8,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_011.1:124,NS_Hs_CART_v1.0,TRBV6-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_016.1:133,NS_Hs_CART_v1.0,TRBV6-8,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_019.1:163,NS_Hs_CART_v1.0,TRBV7-3,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_020.1:125,NS_Hs_CART_v1.0,TRBV7-4,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_028.1:192,NS_Hs_CART_v1.0,TRBV10-3,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_029.1:131,NS_Hs_CART_v1.0,TRBV11-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_035.1:87,NS_Hs_CART_v1.0,TRBV13,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_021.1:189,NS_Hs_CART_v1.0,TRAV13-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_004.1:138,NS_Hs_CART_v1.0,TRBV4-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_005.1:138,NS_Hs_CART_v1.0,TRBV4-3,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_012.1:150,NS_Hs_CART_v1.0,TRBV6-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_018.1:117,NS_Hs_CART_v1.0,TRBV7-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_024.1:13,NS_Hs_CART_v1.0,TRBV7-9,mRNA,0,,,Exhaustion;TCR Diversity;Interactions with Non-lymphoid Cells,,,,,,,,
TCRVB_031.1:73,NS_Hs_CART_v1.0,TRBV11-3,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_034.1:120,NS_Hs_CART_v1.0,TRBV12-5,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_036.1:233,NS_Hs_CART_v1.0,TRBV14,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_037.1:187,NS_Hs_CART_v1.0,TRBV15,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_038.1:194,NS_Hs_CART_v1.0,TRBV16,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_039.1:156,NS_Hs_CART_v1.0,TRBV18,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_041.1:95,NS_Hs_CART_v1.0,TRBV20-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_042.1:124,NS_Hs_CART_v1.0,TRBV24-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_043.1:181,NS_Hs_CART_v1.0,TRBV25-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_002.1:187,NS_Hs_CART_v1.0,TRAV1-2,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_008.1:148,NS_Hs_CART_v1.0,TRBV5-5,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_009.1:145,NS_Hs_CART_v1.0,TRBV5-6,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_022.1:74,NS_Hs_CART_v1.0,TRBV7-7,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVA_042.1:250,NS_Hs_CART_v1.0,TRAV38-1,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_007.1:151,NS_Hs_CART_v1.0,TRBV5-4,mRNA,0,,,TCR Diversity,,,,,,,,
TCRVB_030.1:131,NS_Hs_CART_v1.0,TRBV11-2,mRNA,0,,,TCR Diversity,,,,,,,,
NM_001014987.1:1290,NS_Hs_CART_v1.0,LAT,mRNA,0,,,Toxicity;Activation;TCR signaling;NF-kB;Cytotoxicity,hsa04014;hsa04015;hsa04064;hsa04650;hsa04660;hsa04664;hsa04666,,LAT,,,,,
NM_004946.2:2430,NS_Hs_CART_v1.0,DOCK2,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04062;hsa04666,,DOCK2,,,,,
NM_172099.2:439,NS_Hs_CART_v1.0,CD8B,mRNA,0,,,Exhaustion;Cell Types;Activation;TCR signaling;Interactions with Non-lymphoid Cells,hsa04514;hsa04612;hsa04640;hsa04660;hsa05340,CD8 T cells,CD8B,,,,,
NM_004887.4:1125,NS_Hs_CART_v1.0,CXCL14,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CXCL14,,,,,
NM_006177.3:1504,NS_Hs_CART_v1.0,NRL,mRNA,0,,,Activation;TCR signaling,,,NRL,,,,,
NM_001305.3:1242,NS_Hs_CART_v1.0,CLDN4,mRNA,0,,,Persistence;T-cell migration,hsa04514;hsa04530;hsa04670;hsa05160,,CLDN4,,,,,
NM_002047.2:1230,NS_Hs_CART_v1.0,GARS,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,GARS,,,,,
NM_003201.1:85,NS_Hs_CART_v1.0,TFAM,mRNA,0,,,Metabolism;Mitochondrial biogenesis,hsa05016,,TFAM,,,,,
NM_006335.2:85,NS_Hs_CART_v1.0,TIMM17A,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,TIMM17A,,,,,
NM_001862.2:240,NS_Hs_CART_v1.0,COX5B,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,COX5B,,,,,
NM_015545.2:2895,NS_Hs_CART_v1.0,PTCD1,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,PTCD1,,,,,
NM_201633.2:519,NS_Hs_CART_v1.0,TCF7,mRNA,0,,,Phenotype;Wnt signaling,,,,,,,,
NM_017617.3:8211,NS_Hs_CART_v1.0,NOTCH1,mRNA,0,,,Phenotype;Th2;Notch,hsa04330;hsa04919;hsa05020;hsa05206,,NOTCH1,,,,,
NM_000139.3:126,NS_Hs_CART_v1.0,MS4A2,mRNA,0,,,Cell Types,hsa04071;hsa04072;hsa04664;hsa05310,Mast cells,MS4A2,,,,,
NM_004541.3:240,NS_Hs_CART_v1.0,NDUFA1,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04932;hsa05010;hsa05012;hsa05016,,NDUFA1,,,,,
NM_004889.2:375,NS_Hs_CART_v1.0,ATP5MF,mRNA,0,,,Metabolism;Oxidative phosphorylation;Mitochondrial biogenesis,hsa00190;hsa01100,,ATP5MF,,,,,
NM_005525.2:515,NS_Hs_CART_v1.0,HSD11B1,mRNA,0,,,Cell Types,hsa01100,DC,HSD11B1,,,,,
NM_006441.2:530,NS_Hs_CART_v1.0,MTHFS,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00670;hsa01100,,MTHFS,,,,,
NM_139286.3:280,NS_Hs_CART_v1.0,CDC26,mRNA,0,,,Metabolism;Activation;Cell Cycle;Antigen processing & presentation,hsa04110;hsa04114;hsa04120;hsa04914;hsa05166,,CDC26,,,,,
NM_194284.2:1768,NS_Hs_CART_v1.0,CLDN23,mRNA,0,,,Persistence;T-cell migration,hsa04514;hsa04530;hsa04670;hsa05160,,CLDN23,,,,,
NM_002489.2:35,NS_Hs_CART_v1.0,NDUFA4,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04932;hsa05010;hsa05012;hsa05016,,NDUFA4,,,,,
NM_020905.3:585,NS_Hs_CART_v1.0,RDH14,mRNA,0,,,Phenotype;Vitamin A (RA) signaling,,,RDH14,,,,,
NM_022465.3:4735,NS_Hs_CART_v1.0,IKZF4,mRNA,0,,,Phenotype;Treg,,,IKZF4,,,,,
NM_002260.3:942,NS_Hs_CART_v1.0,KLRC1/2,mRNA,0,,,Toxicity;NKT Receptors;Cytotoxicity,hsa04612;hsa04650,,KLRC2,,,,,
NM_002415.1:319,NS_Hs_CART_v1.0,MIF,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,MIF,,,,,
NM_000189.4:6880,NS_Hs_CART_v1.0,HK2,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00051;hsa01100;hsa01200;hsa04066;hsa04910;hsa04930;hsa04973;hsa05230,,HK2,,,,,
NM_002627.3:795,NS_Hs_CART_v1.0,PFKP,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00030;hsa00051;hsa01100;hsa01200;hsa01230;hsa04152;hsa04919;hsa05230,,PFKP,,,,,
NM_004567.2:400,NS_Hs_CART_v1.0,PFKFB4,mRNA,0,,,Metabolism;Glycolysis,hsa00051;hsa04152,,PFKFB4,,,,,
NM_001014336.1:100,NS_Hs_CART_v1.0,IL31,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL31,,,,,
NM_002675.3:281,NS_Hs_CART_v1.0,PML,mRNA,0,,,Toxicity;Type II interferon signaling,hsa04120;hsa04144;hsa05164;hsa05168;hsa05200;hsa05202;hsa05221,,PML,,,,,
NM_012275.2:2136,NS_Hs_CART_v1.0,IL36RN,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL36RN,,,,,
NM_014439.3:336,NS_Hs_CART_v1.0,IL37,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL37,,,,,
NM_014440.1:45,NS_Hs_CART_v1.0,IL36A,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL36A,,,,,
NM_024021.2:800,NS_Hs_CART_v1.0,MS4A4A,mRNA,0,,,Cell Types,,Macrophages,MS4A4A,,,,,
NM_032556.4:1115,NS_Hs_CART_v1.0,IL1F10,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL1F10,,,,,
NM_032782.3:955,NS_Hs_CART_v1.0,HAVCR2,mRNA,0,,,Exhaustion;Activation;T-cell exhaustion markers;Costimulatory Molecules,,,HAVCR2,,,,,
NM_033439.2:1725,NS_Hs_CART_v1.0,IL33,mRNA,0,,,Toxicity;Phenotype;Activation;Interleukin Signaling;Innate-like T-cells,hsa04623;hsa05164,,IL33,,,,,
NM_148901.1:302,NS_Hs_CART_v1.0,TNFRSF18,mRNA,0,,,Exhaustion;Activation;Costimulatory Molecules,hsa04060,,TNFRSF18,,,,,
NM_005624.2:325,NS_Hs_CART_v1.0,CCL25,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04672,,CCL25,,,,,
NM_145243.3:1410,NS_Hs_CART_v1.0,OMA1,mRNA,0,,,Exhaustion;Apoptosis,,,OMA1,,,,,
NM_022366.2:65,NS_Hs_CART_v1.0,TFB2M,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,TFB2M,,,,,
NM_024013.1:667,NS_Hs_CART_v1.0,IFNA1,mRNA,0,,,Toxicity;Phenotype;Activation;Type I interferon signaling;MAPK and PI3K Signaling;JAK-STAT;Innate-like T-cells;Cytotoxicity,hsa04060;hsa04140;hsa04151;hsa04620;hsa04622;hsa04623;hsa04630;hsa04650;hsa05152;hsa05160;hsa05161;hsa05162;hsa05164;hsa05168;hsa05320,,IFNA1,,,,,
NM_016100.3:585,NS_Hs_CART_v1.0,NAA20,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,NAA20,,,,,
NM_004346.3:2156,NS_Hs_CART_v1.0,CASP3,mRNA,0,,,Toxicity;Exhaustion;Activation;T-cell exhaustion markers;MAPK and PI3K Signaling;Cytotoxicity;Apoptosis,hsa04010;hsa04115;hsa04210;hsa04650;hsa04668;hsa04726;hsa04932;hsa04933;hsa05010;hsa05012;hsa05014;hsa05016;hsa05120;hsa05133;hsa05134;hsa05145;hsa05146;hsa05152;hsa05161;hsa05168;hsa05200;hsa05203;hsa05205;hsa05206;hsa05210;hsa05416,,CASP3,,,,,
NM_000201.2:2253,NS_Hs_CART_v1.0,ICAM1,mRNA,0,,,Toxicity;Persistence;Exhaustion;Type II interferon signaling;T-cell migration;NF-kB;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04064;hsa04514;hsa04650;hsa04668;hsa04670;hsa04933;hsa05143;hsa05144;hsa05150;hsa05164;hsa05166;hsa05169;hsa05323;hsa05416,,ICAM1,,,,,
NM_001042551.1:1855,NS_Hs_CART_v1.0,SMC2,mRNA,0,,,Metabolism;Cell Cycle,,,SMC2,,,,,
NM_017760.5:1630,NS_Hs_CART_v1.0,NCAPG2,mRNA,0,,,Metabolism;Cell Cycle,,,NCAPG2,,,,,
NM_152524.5:3360,NS_Hs_CART_v1.0,SGO2,mRNA,0,,,Metabolism;Cell Cycle,,,SGO2,,,,,
NM_014169.2:770,NS_Hs_CART_v1.0,CHMP4A,mRNA,0,,,Metabolism;Autophagy,hsa04144,,CHMP4A,,,,,
NM_004077.2:740,NS_Hs_CART_v1.0,CS,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00020;hsa00630;hsa01100;hsa01200;hsa01230,,CS,,,,,
NM_006778.3:705,NS_Hs_CART_v1.0,TRIM10,mRNA,0,,,Toxicity;Type II interferon signaling,,,TRIM10,,,,,
NM_013267.2:1945,NS_Hs_CART_v1.0,GLS2,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00250;hsa01100;hsa04724;hsa04727;hsa05206;hsa05230,,GLS2,,,,,
NM_015906.3:3260,NS_Hs_CART_v1.0,TRIM33,mRNA,0,,,Phenotype;TGF-beta,,,TRIM33,,,,,
NM_002382.3:240,NS_Hs_CART_v1.0,MAX,mRNA,0,,,Metabolism;Activation;MAPK and PI3K Signaling;Cell Cycle,hsa04010;hsa05200;hsa05202;hsa05222,,MAX,,,,,
NM_001032409.1:805,NS_Hs_CART_v1.0,OAS1,mRNA,0,,,Toxicity;Type II interferon signaling;Type I interferon signaling,hsa05160;hsa05162;hsa05164;hsa05168,,OAS1,,,,,
NM_001565.2:461,NS_Hs_CART_v1.0,CXCL10,mRNA,0,,,Toxicity;Phenotype;Activation;Innate-like T-cells;Chemokine Signaling,hsa04060;hsa04062;hsa04620;hsa04622;hsa04623;hsa04668;hsa05164,,CXCL10,,,,,
NM_001034173.3:1220,NS_Hs_CART_v1.0,ALDH1L2,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00670,,ALDH1L2,,,,,
NM_014924.3:4520,NS_Hs_CART_v1.0,ATG14,mRNA,0,,,Metabolism;Mitochondrial biogenesis;Autophagy,hsa04140,,ATG14,,,,,
NM_002703.3:1210,NS_Hs_CART_v1.0,PPAT,mRNA,0,,,Activation;Myc targets,hsa00230;hsa00250;hsa01100,,PPAT,,,,,
NM_006404.3:164,NS_Hs_CART_v1.0,PROCR,mRNA,0,,,Exhaustion;T-cell exhaustion markers,,,PROCR,,,,,
NM_023078.2:1145,NS_Hs_CART_v1.0,PYCR3,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00330;hsa01100;hsa01230,,PYCR3,,,,,
NM_002104.2:700,NS_Hs_CART_v1.0,GZMK,mRNA,0,,,Phenotype;Innate-like T-cells,,,GZMK,,,,,
NM_032815.3:1680,NS_Hs_CART_v1.0,NFATC2IP,mRNA,0,,,Activation;NFAT,,,NFATC2IP,,,,,
NM_000616.4:975,NS_Hs_CART_v1.0,CD4,mRNA,0,,,Activation;TCR signaling,hsa04514;hsa04612;hsa04640;hsa04660;hsa05340,,CD4,,,,,
NM_203379.1:2109,NS_Hs_CART_v1.0,ACSL5,mRNA,0,,,Metabolism;Lipid Metabolism,hsa00061;hsa00071;hsa01100;hsa01212;hsa03320;hsa04920,,ACSL5,,,,,
NM_000274.3:775,NS_Hs_CART_v1.0,OAT,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00330;hsa01100,,OAT,,,,,
NM_002801.2:221,NS_Hs_CART_v1.0,PSMB10,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;Wnt signaling;Notch;Cell Cycle;Apoptosis;Antigen processing & presentation,hsa03050,,PSMB10,,,,,
NM_002351.4:495,NS_Hs_CART_v1.0,SH2D1A,mRNA,0,,,Toxicity;Exhaustion;Cell Types;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04650;hsa05162,T-cells,SH2D1A,,,,,
NM_001002295.1:1691,NS_Hs_CART_v1.0,GATA3,mRNA,0,,,Phenotype;Th9;Th2;Th1;Innate-like T-cells,hsa05321,,GATA3,,,,,
NM_005063.4:2025,NS_Hs_CART_v1.0,SCD,mRNA,0,,,Metabolism;Lipid Metabolism,hsa01212;hsa03320;hsa04152,,SCD,,,,,
NR_029467.1:1585,NS_Hs_CART_v1.0,SELL,mRNA,0,,,Phenotype;Exhaustion;Naïve Markers;Memory Markers;Interactions with Non-lymphoid Cells,hsa04514,,SELL,,,,,
NM_004573.2:410,NS_Hs_CART_v1.0,PLCB2,mRNA,0,,,Phenotype;Wnt signaling,hsa01100;hsa04015;hsa04020;hsa04022;hsa04062;hsa04070;hsa04071;hsa04072;hsa04261;hsa04270;hsa04310;hsa04540;hsa04611;hsa04713;hsa04720;hsa04723;hsa04724;hsa04725;hsa04726;hsa04728;hsa04730;hsa04750;hsa04911;hsa04912;hsa04915;hsa04916;hsa04919;hsa04921;hsa04922;hsa04924;hsa04925;hsa04933;hsa04970;hsa04971;hsa04972;hsa04973;hsa05010;hsa05016;hsa05142;hsa05143;hsa05146;hsa05200,,PLCB2,,,,,
NM_000548.3:2380,NS_Hs_CART_v1.0,TSC2,mRNA,0,,,Metabolism;Activation;mTOR;MAPK and PI3K Signaling;Autophagy,hsa04072;hsa04115;hsa04150;hsa04151;hsa04152;hsa04211;hsa04910;hsa04919;hsa05231,,TSC2,,,,,
NM_005417.3:1410,NS_Hs_CART_v1.0,SRC,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04012;hsa04015;hsa04062;hsa04144;hsa04370;hsa04510;hsa04520;hsa04530;hsa04540;hsa04611;hsa04727;hsa04750;hsa04810;hsa04912;hsa04915;hsa04917;hsa04919;hsa04921;hsa05100;hsa05120;hsa05131;hsa05152;hsa05161;hsa05203;hsa05205;hsa05219,,SRC,,,,,
NM_014905.3:985,NS_Hs_CART_v1.0,GLS,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00250;hsa01100;hsa04724;hsa04727;hsa05206;hsa05230,,GLS,,,,,
NM_001716.3:2618,NS_Hs_CART_v1.0,CXCR5,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CXCR5,,,,,
NM_000759.3:851,NS_Hs_CART_v1.0,CSF3,mRNA,0,,,Toxicity;Activation;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04151;hsa04630;hsa04640;hsa05144,,CSF3,,,,,
NM_004632.3:795,NS_Hs_CART_v1.0,DAP3,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,DAP3,,,,,
NM_024408.3:2842,NS_Hs_CART_v1.0,NOTCH2,mRNA,0,,,Phenotype;Th2;Notch,hsa04330;hsa04919;hsa05206,,NOTCH2,,,,,
NM_001571.5:1303,NS_Hs_CART_v1.0,IRF3,mRNA,0,,,Toxicity;Phenotype;Type II interferon signaling;Type I interferon signaling;Innate-like T-cells,hsa04620;hsa04622;hsa04623;hsa05133;hsa05160;hsa05161;hsa05162;hsa05164;hsa05168;hsa05169;hsa05203,,IRF3,,,,,
NM_001228.4:301,NS_Hs_CART_v1.0,CASP8,mRNA,0,,,Phenotype;Exhaustion;Innate-like T-cells;Apoptosis,hsa04115;hsa04210;hsa04620;hsa04621;hsa04622;hsa04668;hsa04932;hsa05010;hsa05016;hsa05134;hsa05142;hsa05145;hsa05152;hsa05161;hsa05168;hsa05200;hsa05203;hsa05416,,CASP8,,,,,
NM_005561.3:730,NS_Hs_CART_v1.0,LAMP1,mRNA,0,,,Metabolism;Autophagy,hsa04142;hsa04145;hsa05152,,LAMP1,,,,,
NM_006664.2:304,NS_Hs_CART_v1.0,CCL27,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL27,,,,,
NM_001165414.1:1690,NS_Hs_CART_v1.0,LDHA,mRNA,0,,,Metabolism;Activation;Oxidative phosphorylation;Myc targets;Glycolysis,hsa00010;hsa00620;hsa01100;hsa04066;hsa04922;hsa05230,,LDHA,,,,,
NM_001003684.1:40,NS_Hs_CART_v1.0,UQCR10,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,UQCR10,,,,,
NM_001136538.1:1905,NS_Hs_CART_v1.0,ACAD10,mRNA,0,,,Metabolism;Lipid Metabolism,,,ACAD10,,,,,
NM_006476.4:192,NS_Hs_CART_v1.0,ATP5MG,mRNA,0,,,Metabolism;Oxidative phosphorylation;Mitochondrial biogenesis,hsa00190;hsa01100,,ATP5MG,,,,,
NM_032963.3:274,NS_Hs_CART_v1.0,CCL14,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL14,,,,,
NM_182744.2:871,NS_Hs_CART_v1.0,NBL1,mRNA,0,,,Phenotype;TGF-beta,hsa04350,,NBL1,,,,,
NM_194294.2:1575,NS_Hs_CART_v1.0,IDO2,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa01100;hsa05143,,IDO2,,,,,
NM_021034.2:40,NS_Hs_CART_v1.0,IFITM3,mRNA,0,,,Toxicity;Type I interferon signaling,,,IFITM3,,,,,
NM_001100812.1:850,NS_Hs_CART_v1.0,CXCL16,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CXCL16,,,,,
NM_005409.4:282,NS_Hs_CART_v1.0,CXCL11,mRNA,0,,,Toxicity;Phenotype;Activation;Innate-like T-cells;Chemokine Signaling,hsa04060;hsa04062;hsa04620,,CXCL11,,,,,
NM_013371.3:1030,NS_Hs_CART_v1.0,IL19,mRNA,0,,,Toxicity;Activation;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630,,IL19,,,,,
NM_016817.2:480,NS_Hs_CART_v1.0,OAS2,mRNA,0,,,Toxicity;Type II interferon signaling;Type I interferon signaling,hsa05160;hsa05162;hsa05164;hsa05168,,OAS2,,,,,
NM_006821.4:215,NS_Hs_CART_v1.0,ACOT2,mRNA,0,,,Metabolism;Lipid Metabolism,hsa01100,,ACOT2,,,,,
NM_001198909.1:673,NS_Hs_CART_v1.0,ATP6V1F,mRNA,0,,,Metabolism;Oxidative phosphorylation;mTOR,hsa00190;hsa01100;hsa04145;hsa05120;hsa05323,,ATP6V1F,,,,,
NM_000657.2:947,NS_Hs_CART_v1.0,BCL2,mRNA,0,,,Toxicity;Metabolism;Exhaustion;Activation;NF-kB;MAPK and PI3K Signaling;JAK-STAT;Autophagy;Apoptosis,hsa04064;hsa04066;hsa04071;hsa04151;hsa04210;hsa04261;hsa04510;hsa04630;hsa04722;hsa04725;hsa04933;hsa05014;hsa05145;hsa05152;hsa05161;hsa05169;hsa05200;hsa05206;hsa05210;hsa05215;hsa05222,,BCL2,,,,,
NM_000932.2:429,NS_Hs_CART_v1.0,PLCB3,mRNA,0,,,Phenotype;Wnt signaling,hsa01100;hsa04015;hsa04020;hsa04022;hsa04062;hsa04070;hsa04071;hsa04072;hsa04261;hsa04270;hsa04310;hsa04540;hsa04611;hsa04713;hsa04720;hsa04723;hsa04724;hsa04725;hsa04726;hsa04728;hsa04730;hsa04750;hsa04911;hsa04912;hsa04915;hsa04916;hsa04919;hsa04921;hsa04922;hsa04924;hsa04925;hsa04933;hsa04970;hsa04971;hsa04972;hsa05010;hsa05016;hsa05142;hsa05143;hsa05146;hsa05200,,PLCB3,,,,,
NM_001004057.1:1294,NS_Hs_CART_v1.0,GRK4,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04062;hsa04144;hsa05032,,GRK4,,,,,
NM_145803.2:745,NS_Hs_CART_v1.0,TRAF6,mRNA,0,,,Toxicity;Phenotype;Metabolism;Activation;NF-kB;MAPK and PI3K Signaling;Innate-like T-cells;Autophagy,hsa04010;hsa04064;hsa04120;hsa04144;hsa04380;hsa04620;hsa04621;hsa04622;hsa04722;hsa05133;hsa05140;hsa05142;hsa05145;hsa05152;hsa05160;hsa05162;hsa05168;hsa05169;hsa05200;hsa05222,,TRAF6,,,,,
NM_003113.3:911,NS_Hs_CART_v1.0,SP100,mRNA,0,,,Toxicity;Type II interferon signaling,hsa05168;hsa05203,,SP100,,,,,
NM_000859.2:555,NS_Hs_CART_v1.0,HMGCR,mRNA,0,,,Metabolism;Lipid Metabolism,hsa01100;hsa04152,,HMGCR,,,,,
NM_001128849.1:1480,NS_Hs_CART_v1.0,SMARCA4,mRNA,0,,,Phenotype;Wnt signaling,,,SMARCA4,,,,,
NM_021809.6:1270,NS_Hs_CART_v1.0,TGIF2,mRNA,0,,,Phenotype;TGF-beta,hsa04350,,TGIF2,,,,,
NM_014756.2:1415,NS_Hs_CART_v1.0,CKAP5,mRNA,0,,,Metabolism;Cell Cycle,,,CKAP5,,,,,
NM_000536.3:655,NS_Hs_CART_v1.0,RAG2,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,hsa04068;hsa05340,,RAG2,,,,,
NM_001531.2:7695,NS_Hs_CART_v1.0,MR1,mRNA,0,,,Phenotype;Innate-like T-cells,,,MR1,,,,,
NM_002497.3:480,NS_Hs_CART_v1.0,NEK2,mRNA,0,,,Metabolism;Cell Cycle,,,NEK2,,,,,
NM_018486.2:387,NS_Hs_CART_v1.0,HDAC8,mRNA,0,,,Phenotype;Notch,hsa05034;hsa05203,,HDAC8,,,,,
NM_145259.2:5168,NS_Hs_CART_v1.0,ACVR1C,mRNA,0,,,Phenotype;TGF-beta,hsa04350;hsa04550,,ACVR1C,,,,,
NM_016079.3:95,NS_Hs_CART_v1.0,CHMP3,mRNA,0,,,Metabolism;Autophagy,hsa04144,,CHMP3,,,,,
NM_001127208.2:2882,NS_Hs_CART_v1.0,TET2,mRNA,0,,,Metabolism,,,TET2,,,,,
NM_001331.2:146,NS_Hs_CART_v1.0,CTNND1,mRNA,0,,,Persistence;T-cell migration,hsa04015;hsa04520;hsa04670,,CTNND1,,,,,
NM_000073.2:404,NS_Hs_CART_v1.0,CD3G,mRNA,0,,,Exhaustion;Cell Types;Activation;TCR signaling;Interactions with Non-lymphoid Cells,hsa04640;hsa04660;hsa05142;hsa05162;hsa05166,T-cells,CD3G,,,,,
NM_001119.4:622,NS_Hs_CART_v1.0,ADD1,mRNA,0,,,Exhaustion;Apoptosis,,,ADD1,,,,,
NM_184041.2:1455,NS_Hs_CART_v1.0,ALDOA,mRNA,0,,,Metabolism;Glycolysis,hsa00010;hsa00030;hsa00051;hsa01100;hsa01200;hsa01230;hsa04066,,ALDOA,,,,,
NM_001018137.2:669,NS_Hs_CART_v1.0,NME2,mRNA,0,,,Activation;Myc targets,hsa00230;hsa01100,,NME2,,,,,
NM_001166356.1:1460,NS_Hs_CART_v1.0,SHMT2,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00260;hsa00630;hsa00670;hsa01100;hsa01200;hsa01230,,SHMT2,,,,,
NM_030662.3:839,NS_Hs_CART_v1.0,MAP2K2,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;TCR signaling;mTOR;MAPK and PI3K Signaling;Innate-like T-cells;Autophagy;Apoptosis,hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04066;hsa04068;hsa04071;hsa04072;hsa04151;hsa04270;hsa04370;hsa04540;hsa04550;hsa04620;hsa04650;hsa04660;hsa04662;hsa04664;hsa04720;hsa04722;hsa04730;hsa04810;hsa04910;hsa04912;hsa04915;hsa04916;hsa04917;hsa04919;hsa04921;hsa05020;hsa05161;hsa05164;hsa05200;hsa05205;hsa05206;hsa05211;hsa05213;hsa05214;hsa05215;hsa05216;hsa05218;hsa05219;hsa05220;hsa05221;hsa05223;hsa05230;hsa05231,,MAP2K2,,,,,
NM_001654.3:245,NS_Hs_CART_v1.0,ARAF,mRNA,0,,,Toxicity;Activation;MAPK and PI3K Signaling;Cytotoxicity,hsa04012;hsa04068;hsa04270;hsa04650;hsa04720;hsa04726;hsa04730;hsa04810;hsa04910;hsa04914;hsa05034;hsa05160;hsa05200;hsa05205;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05219;hsa05220;hsa05221;hsa05223,,ARAF,,,,,
NM_006156.2:330,NS_Hs_CART_v1.0,NEDD8,mRNA,0,,,Phenotype;TGF-beta,,,NEDD8,,,,,
NM_001039476.2:1145,NS_Hs_CART_v1.0,NPRL3,mRNA,0,,,Metabolism;mTOR,,,NPRL3,,,,,
NM_005816.4:428,NS_Hs_CART_v1.0,CD96,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells,,,CD96,,,,,
NM_199072.4:85,NS_Hs_CART_v1.0,MDFIC,mRNA,0,,,Exhaustion;T-cell exhaustion markers,,,MDFIC,,,,,
NM_000801.4:40,NS_Hs_CART_v1.0,FKBP1A,mRNA,0,,,Phenotype;Activation;TGF-beta;NFAT,,,FKBP1A,,,,,
NM_020761.2:6665,NS_Hs_CART_v1.0,RPTOR,mRNA,0,,,Metabolism;Activation;mTOR;MAPK and PI3K Signaling;Autophagy,hsa04150;hsa04151;hsa04152;hsa04211;hsa04213;hsa04910;hsa05206,,RPTOR,,,,,
NM_001039659.1:1045,NS_Hs_CART_v1.0,IL18BP,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL18BP,,,,,
NM_001242783.1:2140,NS_Hs_CART_v1.0,TRIM26,mRNA,0,,,Toxicity;Type II interferon signaling,,,TRIM26,,,,,
NM_145725.2:720,NS_Hs_CART_v1.0,TRAF3,mRNA,0,,,Toxicity;Phenotype;NF-kB;Innate-like T-cells,hsa04064;hsa04620;hsa04622;hsa04668;hsa05160;hsa05168;hsa05169;hsa05200;hsa05203;hsa05222,,TRAF3,,,,,
NM_025196.2:955,NS_Hs_CART_v1.0,GRPEL1,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,GRPEL1,,,,,
NM_000284.3:1080,NS_Hs_CART_v1.0,PDHA1,mRNA,0,,,Phenotype;Metabolism;Vitamin A (RA) signaling;Oxidative phosphorylation;Glycolysis,hsa00010;hsa00020;hsa00620;hsa01100;hsa01200;hsa04066;hsa04922;hsa05230,,PDHA1,,,,,
NM_001636.3:1080,NS_Hs_CART_v1.0,SLC25A6,mRNA,0,,,Metabolism;Mitochondrial biogenesis,hsa04020;hsa04022;hsa05012;hsa05016;hsa05164;hsa05166,,SLC25A6,,,,,
NM_006150.3:1613,NS_Hs_CART_v1.0,PRICKLE3,mRNA,0,,,Phenotype;Wnt signaling,,,PRICKLE3,,,,,
NM_005901.5:1678,NS_Hs_CART_v1.0,SMAD2,mRNA,0,,,Phenotype;Metabolism;Treg;Th9;Th17;TGF-beta;Cell Cycle,hsa04068;hsa04110;hsa04144;hsa04350;hsa04390;hsa04520;hsa04550;hsa04933;hsa05142;hsa05166;hsa05200;hsa05205;hsa05210;hsa05212;hsa05321,,SMAD2,,,,,
NM_005918.3:77,NS_Hs_CART_v1.0,MDH2,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00020;hsa00620;hsa00630;hsa01100;hsa01200,,MDH2,,,,,
NM_021975.3:1990,NS_Hs_CART_v1.0,RELA,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Activation;Th9;Th1;TCR signaling;NF-kB;MAPK and PI3K Signaling;Interleukin Signaling;Innate-like T-cells;Apoptosis,hsa04010;hsa04014;hsa04024;hsa04062;hsa04064;hsa04066;hsa04071;hsa04151;hsa04210;hsa04211;hsa04380;hsa04620;hsa04621;hsa04622;hsa04623;hsa04660;hsa04662;hsa04668;hsa04722;hsa04917;hsa04920;hsa04931;hsa04932;hsa04933;hsa05030;hsa05120;hsa05131;hsa05132;hsa05133;hsa05134;hsa05140;hsa05142;hsa05145;hsa05146;hsa05152;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05168;hsa05169;hsa05200;hsa05202;hsa05203;hsa05212;hsa05215;hsa05220;hsa05221;hsa05222;hsa05321,,RELA,,,,,
NM_002079.2:615,NS_Hs_CART_v1.0,GOT1,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00250;hsa00330;hsa01100;hsa01200;hsa01230,,GOT1,,,,,
NM_002982.3:123,NS_Hs_CART_v1.0,CCL2,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04621;hsa04668;hsa04933;hsa05142;hsa05144;hsa05164;hsa05168;hsa05323,,CCL2,,,,,
NM_002038.3:432,NS_Hs_CART_v1.0,IFI6,mRNA,0,,,Toxicity;Type I interferon signaling,,,IFI6,,,,,
NM_022153.1:1955,NS_Hs_CART_v1.0,VSIR,mRNA,0,,,Exhaustion;Activation;Costimulatory Molecules,,,VSIR,,,,,
NM_001243078.1:2065,NS_Hs_CART_v1.0,CD28,mRNA,0,,,Exhaustion;Activation;TCR signaling;Costimulatory Molecules,hsa04514;hsa04660;hsa04672;hsa04940;hsa05162;hsa05320;hsa05322;hsa05323;hsa05330;hsa05332;hsa05416,,CD28,,,,,
NM_002983.2:159,NS_Hs_CART_v1.0,CCL3/L1,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Activation;T-cell exhaustion markers;Innate-like T-cells;Chemokine Signaling,hsa04060;hsa04062;hsa04620;hsa05132;hsa05142;hsa05323,,CCL3,,,,,
NM_002984.2:201,NS_Hs_CART_v1.0,CCL4/L1,mRNA,0,,,Toxicity;Phenotype;Activation;NF-kB;Innate-like T-cells;Chemokine Signaling,hsa04060;hsa04062;hsa04064;hsa04620;hsa04623;hsa05132,,CCL4,,,,,
NM_014402.4:172,NS_Hs_CART_v1.0,UQCRQ,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,UQCRQ,,,,,
NM_013278.3:798,NS_Hs_CART_v1.0,IL17C,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL17C,,,,,
NM_014438.3:71,NS_Hs_CART_v1.0,IL36B,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL36B,,,,,
NM_001033910.2:1690,NS_Hs_CART_v1.0,TRAF5,mRNA,0,,,Toxicity;NF-kB,hsa04064;hsa04668;hsa05168;hsa05169;hsa05200;hsa05203;hsa05222,,TRAF5,,,,,
NM_006097.3:772,NS_Hs_CART_v1.0,MYL9,mRNA,0,,,Persistence;T-cell migration,hsa04022;hsa04024;hsa04270;hsa04510;hsa04530;hsa04670;hsa04810;hsa04921,,MYL9,,,,,
NM_002995.2:266,NS_Hs_CART_v1.0,XCL1/2,mRNA,0,,,Toxicity;Cell Types;Activation;Chemokine Signaling,hsa04060;hsa04062,NK cells,XCL1,,,,,
NM_001012662.2:1505,NS_Hs_CART_v1.0,SLC3A2,mRNA,0,,,Metabolism;mTOR,,,SLC3A2,,,,,
NM_181879.2:545,NS_Hs_CART_v1.0,LILRA5,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa04380,,LILRA5,,,,,
NM_021004.2:964,NS_Hs_CART_v1.0,DHRS4,mRNA,0,,,Phenotype;Vitamin A (RA) signaling,hsa01100,,DHRS4,,,,,
NM_181339.1:1016,NS_Hs_CART_v1.0,IL24,mRNA,0,,,Toxicity;Activation;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630,,IL24,,,,,
NM_172389.1:1984,NS_Hs_CART_v1.0,NFATC1,mRNA,0,,,Toxicity;Phenotype;Activation;Wnt signaling;TCR signaling;NFAT;MAPK and PI3K Signaling;Cytotoxicity,hsa04010;hsa04022;hsa04024;hsa04310;hsa04380;hsa04650;hsa04660;hsa04662;hsa04921;hsa04933;hsa05161;hsa05166;hsa05321,,NFATC1,,,,,
NM_005530.2:1521,NS_Hs_CART_v1.0,IDH3A,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00020;hsa01100;hsa01200;hsa01230,,IDH3A,,,,,
NM_001185012.1:116,NS_Hs_CART_v1.0,NDUFA2,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04932;hsa05010;hsa05012;hsa05016,,NDUFA2,,,,,
NM_002490.3:430,NS_Hs_CART_v1.0,NDUFA6,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04932;hsa05010;hsa05012;hsa05016,,NDUFA6,,,,,
NM_012190.2:329,NS_Hs_CART_v1.0,ALDH1L1,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00670,,ALDH1L1,,,,,
NM_017897.2:215,NS_Hs_CART_v1.0,OXSM,mRNA,0,,,Metabolism;Lipid Metabolism,hsa00061;hsa01100;hsa01212,,OXSM,,,,,
NM_005384.2:1795,NS_Hs_CART_v1.0,NFIL3,mRNA,0,,,Phenotype;Metabolism;Innate-like T-cells;Circadian Clock,,,NFIL3,,,,,
NM_198390.2:2662,NS_Hs_CART_v1.0,CMIP,mRNA,0,,,Activation;TCR signaling,,,CMIP,,,,,
ENST00000390477.1:310,NS_Hs_CART_v1.0,TRDC,mRNA,0,,,TCR Diversity,,,,,,,,
NM_000629.2:782,NS_Hs_CART_v1.0,IFNAR1,mRNA,0,,,Toxicity;Phenotype;Activation;Type I interferon signaling;MAPK and PI3K Signaling;JAK-STAT;Innate-like T-cells;Cytotoxicity,hsa04060;hsa04151;hsa04380;hsa04620;hsa04630;hsa04650;hsa05160;hsa05161;hsa05162;hsa05164;hsa05168,,IFNAR1,,,,,
NM_001250.4:196,NS_Hs_CART_v1.0,CD40,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Activation;NF-kB;Innate-like T-cells;Costimulatory Molecules,hsa04060;hsa04064;hsa04514;hsa04620;hsa04672;hsa05144;hsa05145;hsa05166;hsa05169;hsa05202;hsa05310;hsa05320;hsa05322;hsa05330;hsa05340;hsa05416,,CD40,,,,,
NM_021133.3:1094,NS_Hs_CART_v1.0,RNASEL,mRNA,0,,,Toxicity;Type I interferon signaling,hsa05160;hsa05164;hsa05168,,RNASEL,,,,,
NM_006238.4:895,NS_Hs_CART_v1.0,PPARD,mRNA,0,,,Phenotype;Metabolism;Wnt signaling;Vitamin A (RA) signaling;Oxidative phosphorylation;Lipid Metabolism,hsa03320;hsa04310;hsa05200;hsa05221,,PPARD,,,,,
NM_001242767.1:525,NS_Hs_CART_v1.0,MTHFD1L,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00670;hsa01100,,MTHFD1L,,,,,
NM_203468.1:206,NS_Hs_CART_v1.0,ENTPD2,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa00230,,ENTPD2,,,,,
NM_001359.1:835,NS_Hs_CART_v1.0,DECR1,mRNA,0,,,Metabolism;Lipid Metabolism,,,DECR1,,,,,
NM_001039802.1:390,NS_Hs_CART_v1.0,CDC42,mRNA,0,,,Persistence;Activation;TCR signaling;T-cell migration;MAPK and PI3K Signaling,hsa04010;hsa04014;hsa04015;hsa04062;hsa04144;hsa04360;hsa04370;hsa04510;hsa04520;hsa04530;hsa04660;hsa04666;hsa04670;hsa04722;hsa04810;hsa04912;hsa04932;hsa04933;hsa05100;hsa05120;hsa05130;hsa05131;hsa05132;hsa05200;hsa05203;hsa05205;hsa05211;hsa05212,,CDC42,,,,,
NM_032622.2:1675,NS_Hs_CART_v1.0,LNX1,mRNA,0,,,Activation;Antigen processing & presentation,,,LNX1,,,,,
NM_001876.3:1355,NS_Hs_CART_v1.0,CPT1A,mRNA,0,,,Phenotype;Metabolism;Vitamin A (RA) signaling;Mitochondrial biogenesis;Lipid Metabolism;Circadian Clock,hsa00071;hsa01212;hsa03320;hsa04152;hsa04920;hsa04922;hsa04931,,CPT1A,,,,,
NM_000183.2:1174,NS_Hs_CART_v1.0,HADHB,mRNA,0,,,Metabolism;Lipid Metabolism,hsa00071;hsa01100;hsa01212,,HADHB,,,,,
NM_007053.3:722,NS_Hs_CART_v1.0,CD160,mRNA,0,,,Toxicity;Exhaustion;T-cell exhaustion markers;NKT Receptors;Interactions with Non-lymphoid Cells,,,CD160,,,,,
NM_002309.3:1240,NS_Hs_CART_v1.0,LIF,mRNA,0,,,Toxicity;Activation;JAK-STAT;Interleukin Signaling,hsa04060;hsa04550;hsa04630;hsa04668,,LIF,,,,,
NM_002996.3:1216,NS_Hs_CART_v1.0,CX3CL1,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa04668,,CX3CL1,,,,,
NM_199168.3:69,NS_Hs_CART_v1.0,CXCL12,mRNA,0,,,Toxicity;Persistence;Activation;T-cell migration;NF-kB;Chemokine Signaling,hsa04060;hsa04062;hsa04064;hsa04360;hsa04670;hsa04672;hsa05200;hsa05323,,CXCL12,,,,,
NM_004829.5:602,NS_Hs_CART_v1.0,NCR1,mRNA,0,,,Toxicity;Exhaustion;Cell Types;NKT Receptors;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04650,NK cells,NCR1,,,,,
NM_001123041.2:743,NS_Hs_CART_v1.0,CCR2,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCR2,,,,,
NM_147130.2:655,NS_Hs_CART_v1.0,NCR3,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04650,,NCR3,,,,,
NM_004221.4:358,NS_Hs_CART_v1.0,IL32,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL32,,,,,
NM_004336.3:1978,NS_Hs_CART_v1.0,BUB1,mRNA,0,,,Metabolism;Cell Cycle,hsa04110;hsa04114;hsa04914,,BUB1,,,,,
NM_014874.3:2010,NS_Hs_CART_v1.0,MFN2,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,MFN2,,,,,
NM_001033853.1:145,NS_Hs_CART_v1.0,RPL3,mRNA,0,,,Activation;Myc targets,,,RPL3,,,,,
NR_049726.1:543,NS_Hs_CART_v1.0,TCL1A,mRNA,0,,,Cell Types;Activation;MAPK and PI3K Signaling,hsa04151,B-cells,TCL1A,,,,,
NM_004612.2:1255,NS_Hs_CART_v1.0,TGFBR1,mRNA,0,,,Phenotype;Activation;Treg;Th9;Th17;TGF-beta;MAPK and PI3K Signaling,hsa04010;hsa04060;hsa04068;hsa04144;hsa04350;hsa04380;hsa04390;hsa04520;hsa04933;hsa05142;hsa05161;hsa05166;hsa05200;hsa05210;hsa05212;hsa05220,,TGFBR1,,,,,
NM_000416.2:392,NS_Hs_CART_v1.0,IFNGR1,mRNA,0,,,Toxicity;Phenotype;Activation;Type II interferon signaling;Th1;JAK-STAT;Cytotoxicity,hsa04060;hsa04066;hsa04380;hsa04630;hsa04650;hsa05132;hsa05140;hsa05142;hsa05145;hsa05152;hsa05162;hsa05164;hsa05168;hsa05321,,IFNGR1,,,,,
NM_144701.2:1800,NS_Hs_CART_v1.0,IL23R,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa05321,,IL23R,,,,,
NM_006006.4:800,NS_Hs_CART_v1.0,ZBTB16,mRNA,0,,,Phenotype;Activation;Innate-like T-cells;Antigen processing & presentation,hsa05200;hsa05202;hsa05221,,ZBTB16,,,,,
NM_000958.2:976,NS_Hs_CART_v1.0,PTGER4,mRNA,0,,,Cell Types,hsa04080;hsa04750;hsa04924;hsa05200,Exhausted CD8,PTGER4,,,,,
NM_001014432.1:1275,NS_Hs_CART_v1.0,AKT1,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;Wnt signaling;TCR signaling;Notch;mTOR;MAPK and PI3K Signaling;JAK-STAT;Innate-like T-cells;Cell Cycle;Autophagy;Apoptosis,hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04071;hsa04072;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04261;hsa04370;hsa04380;hsa04510;hsa04530;hsa04550;hsa04611;hsa04620;hsa04630;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04722;hsa04725;hsa04728;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04920;hsa04922;hsa04923;hsa04931;hsa04932;hsa04933;hsa04973;hsa05142;hsa05145;hsa05152;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05169;hsa05200;hsa05205;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05230;hsa05231,,AKT1,,,,,
NM_001145645.2:240,NS_Hs_CART_v1.0,TNFSF13B,mRNA,0,,,Toxicity;NF-kB,hsa04060;hsa04064;hsa04672;hsa05323,,TNFSF13B,,,,,
NM_004958.3:1865,NS_Hs_CART_v1.0,MTOR,mRNA,0,,,Phenotype;Metabolism;Activation;Th17;mTOR;MAPK and PI3K Signaling;JAK-STAT;Autophagy,hsa04012;hsa04066;hsa04072;hsa04150;hsa04151;hsa04152;hsa04211;hsa04213;hsa04630;hsa04910;hsa04919;hsa04920;hsa04930;hsa04931;hsa05200;hsa05205;hsa05206;hsa05214;hsa05215;hsa05221;hsa05230;hsa05231,,MTOR,,,,,
NM_030665.3:4652,NS_Hs_CART_v1.0,RAI1,mRNA,0,,,Metabolism;Circadian Clock,,,RAI1,,,,,
NM_001040000.2:3780,NS_Hs_CART_v1.0,AFDN,mRNA,0,,,Persistence;T-cell migration,hsa04014;hsa04015;hsa04024;hsa04520;hsa04530;hsa04670,,AFDN,,,,,
NM_006419.2:210,NS_Hs_CART_v1.0,CXCL13,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CXCL13,,,,,
NM_001098416.2:416,NS_Hs_CART_v1.0,HDAC7,mRNA,0,,,Phenotype;Notch,hsa05034;hsa05203,,HDAC7,,,,,
NM_000600.3:364,NS_Hs_CART_v1.0,IL6,mRNA,0,,,Toxicity;Phenotype;Activation;Th2;Th17;Tfh;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling;Innate-like T-cells,hsa04060;hsa04066;hsa04068;hsa04151;hsa04620;hsa04621;hsa04623;hsa04630;hsa04640;hsa04668;hsa04672;hsa04931;hsa04932;hsa04933;hsa05020;hsa05132;hsa05133;hsa05134;hsa05142;hsa05143;hsa05144;hsa05146;hsa05152;hsa05161;hsa05162;hsa05164;hsa05166;hsa05168;hsa05200;hsa05202;hsa05321;hsa05323;hsa05332,,IL6,,,,,
NM_006399.3:293,NS_Hs_CART_v1.0,BATF,mRNA,0,,,Phenotype;Exhaustion;Activation;Tfh;TCR signaling;T-cell exhaustion markers,,,BATF,,,,,
NM_018664.2:770,NS_Hs_CART_v1.0,BATF3,mRNA,0,,,Activation;Antigen processing & presentation,,,BATF3,,,,,
NM_001144899.1:950,NS_Hs_CART_v1.0,CD209,mRNA,0,,,Cell Types,hsa04145;hsa05152;hsa05162,DC,CD209,,,,,
NM_001626.4:699,NS_Hs_CART_v1.0,AKT2,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;Wnt signaling;TCR signaling;mTOR;MAPK and PI3K Signaling;JAK-STAT;Innate-like T-cells;Cell Cycle;Autophagy;Apoptosis,hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04071;hsa04072;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04261;hsa04370;hsa04380;hsa04510;hsa04530;hsa04550;hsa04611;hsa04620;hsa04630;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04722;hsa04725;hsa04728;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04920;hsa04922;hsa04923;hsa04931;hsa04932;hsa04933;hsa04973;hsa05142;hsa05145;hsa05152;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05169;hsa05200;hsa05205;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05230;hsa05231,,AKT2,,,,,
NM_001963.4:1022,NS_Hs_CART_v1.0,EGF,mRNA,0,,,Phenotype;Activation;Notch;MAPK and PI3K Signaling;JAK-STAT,hsa04010;hsa04012;hsa04014;hsa04015;hsa04060;hsa04066;hsa04068;hsa04072;hsa04144;hsa04151;hsa04510;hsa04540;hsa04810;hsa05160;hsa05200;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05219;hsa05223;hsa05231,,EGF,,,,,
NM_000387.5:1458,NS_Hs_CART_v1.0,SLC25A20,mRNA,0,,,Metabolism;Lipid Metabolism,,,SLC25A20,,,,,
NM_021130.3:315,NS_Hs_CART_v1.0,PPIA,mRNA,0,,,Activation;NFAT,,,PPIA,,,,,
NM_003264.3:2402,NS_Hs_CART_v1.0,TLR2,mRNA,0,,,Phenotype;Activation;MAPK and PI3K Signaling;Innate-like T-cells;Antigen processing & presentation,hsa04145;hsa04151;hsa04620;hsa05134;hsa05140;hsa05142;hsa05144;hsa05145;hsa05146;hsa05152;hsa05161;hsa05162;hsa05168;hsa05205;hsa05321;hsa05323,,TLR2,,,,,
NM_017907.2:344,NS_Hs_CART_v1.0,LAMTOR1,mRNA,0,,,Metabolism;mTOR;Autophagy,,,LAMTOR1,,,,,
NM_002838.4:258,NS_Hs_CART_v1.0,CD45RA,mRNA,0,,NM_080921.2:90;NM_080921.3:258,Cell Types;Activation;TCR signaling,hsa04514;hsa04660;hsa04666;hsa05340,CD45,PTPRC,,,,,
NM_080921.3:258,NS_Hs_CART_v1.0,CD45R0,mRNA,0,,NM_080921.2:90;NM_002838.4:258,Cell Types;Activation;TCR signaling,hsa04514;hsa04660;hsa04666;hsa05340,CD45,PTPRC,,,,,
NM_001130140.1:155,NS_Hs_CART_v1.0,ERAP2,mRNA,0,,,Activation;Antigen processing & presentation,,,ERAP2,,,,,
NM_002112.3:1170,NS_Hs_CART_v1.0,HDC,mRNA,0,,,Cell Types,hsa01100,Mast cells,HDC,,,,,
NM_001193480.1:2106,NS_Hs_CART_v1.0,ALDH8A1,mRNA,0,,,Phenotype;Vitamin A (RA) signaling,,,ALDH8A1,,,,,
NM_004379.3:618,NS_Hs_CART_v1.0,CREB1,mRNA,0,,,Phenotype;Metabolism;Activation;Notch;Mitochondrial biogenesis;MAPK and PI3K Signaling;Circadian Clock,hsa04022;hsa04024;hsa04151;hsa04152;hsa04211;hsa04261;hsa04380;hsa04612;hsa04668;hsa04710;hsa04713;hsa04725;hsa04728;hsa04911;hsa04915;hsa04916;hsa04922;hsa04924;hsa04925;hsa04931;hsa05016;hsa05030;hsa05031;hsa05034;hsa05152;hsa05161;hsa05166;hsa05203;hsa05215,,CREB1,,,,,
NM_004828.3:306,NS_Hs_CART_v1.0,NCR2,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04650,,NCR2,,,,,
NM_014729.2:574,NS_Hs_CART_v1.0,TOX,mRNA,0,,,Exhaustion;T-cell exhaustion markers,,,TOX,,,,,
NM_003332.3:361,NS_Hs_CART_v1.0,TYROBP,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04380;hsa04650,,TYROBP,,,,,
ENST00000466254.1:282,NS_Hs_CART_v1.0,TRBC1/2,mRNA,0,,,TCR Diversity,,,,,,,,
NM_000570.4:696,NS_Hs_CART_v1.0,FCGR3A/B,mRNA,0,,,Toxicity;Cell Types;Cytotoxicity,hsa04145;hsa04380;hsa04650;hsa05140;hsa05150;hsa05152;hsa05322,Neutrophils,FCGR3B,,,,,
ENST00000390345.1:3,NS_Hs_CART_v1.0,TRGV4,mRNA,0,,,TCR Diversity,,,,,,,,
NM_005360.4:888,NS_Hs_CART_v1.0,MAF,mRNA,0,,,Phenotype;Th2;Tfh,hsa05202;hsa05321,,MAF,,,,,
NM_019618.3:682,NS_Hs_CART_v1.0,IL36G,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,IL36G,,,,,
NM_001867.2:57,NS_Hs_CART_v1.0,COX7C,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,COX7C,,,,,
ENST00000436911.1:297,NS_Hs_CART_v1.0,TRGC2,mRNA,0,,,TCR Diversity,,,,,,,,
NM_001815.3:527,NS_Hs_CART_v1.0,CEACAM3,mRNA,0,,,Cell Types,,Neutrophils,CEACAM3,,,,,
NM_003839.3:226,NS_Hs_CART_v1.0,TNFRSF11A,mRNA,0,,,Toxicity;NF-kB,hsa04060;hsa04064;hsa04380;hsa04917;hsa05323,,TNFRSF11A,,,,,
NR_026800.2:9125,NS_Hs_CART_v1.0,FAM30A,mRNA,0,,,Cell Types,,B-cells,FAM30A,,,,,
NM_000760.3:2066,NS_Hs_CART_v1.0,CSF3R,mRNA,0,,,Cell Types;Activation;MAPK and PI3K Signaling;JAK-STAT,hsa04060;hsa04151;hsa04630;hsa04640;hsa05200,Neutrophils,CSF3R,,,,,
NM_001008738.2:1264,NS_Hs_CART_v1.0,FNIP1,mRNA,0,,,Metabolism;mTOR,,,FNIP1,,,,,
NM_001031617.2:2342,NS_Hs_CART_v1.0,COX19,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,COX19,,,,,
NM_001102369.2:442,NS_Hs_CART_v1.0,DGLUCY,mRNA,0,,,Metabolism;Glutamine metabolism,,,DGLUCY,,,,,
NM_001134493.1:478,NS_Hs_CART_v1.0,TOMM6,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,TOMM6,,,,,
NM_001184879.1:28,NS_Hs_CART_v1.0,CD84,mRNA,0,,,Cell Types,,Macrophages,CD84,,,,,
NM_001195643.1:352,NS_Hs_CART_v1.0,DHFR2,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00670;hsa01100,,DHFR2,,,,,
NM_001204090.1:22,NS_Hs_CART_v1.0,COX16,mRNA,0,,,Metabolism;Oxidative phosphorylation;Mitochondrial biogenesis,,,COX16,,,,,
NM_001204103.1:1520,NS_Hs_CART_v1.0,PPT2,mRNA,0,,,Metabolism;Lipid Metabolism,hsa01100;hsa01212;hsa04142,,PPT2,,,,,
NM_001242589.1:344,NS_Hs_CART_v1.0,TREM1,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,,,TREM1,,,,,
NM_001254751.1:1722,NS_Hs_CART_v1.0,CD6,mRNA,0,,,Cell Types,hsa04514,T-cells,CD6,,,,,
NM_001270447.1:296,NS_Hs_CART_v1.0,ACADVL,mRNA,0,,,Metabolism;Lipid Metabolism,hsa00071;hsa01100;hsa01212,,ACADVL,,,,,
NM_001278405.1:256,NS_Hs_CART_v1.0,LILRB2,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa04380,,LILRB2,,,,,
NM_001863.4:264,NS_Hs_CART_v1.0,COX6B1,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,COX6B1,,,,,
NM_001903.2:1766,NS_Hs_CART_v1.0,CTNNA1,mRNA,0,,,Persistence;T-cell migration,hsa04390;hsa04520;hsa04530;hsa04670;hsa05100;hsa05200;hsa05213,,CTNNA1,,,,,
NM_003610.3:980,NS_Hs_CART_v1.0,RAE1,mRNA,0,,,Metabolism;Glycolysis;Cell Cycle,hsa05164,,RAE1,,,,,
NM_003629.3:5016,NS_Hs_CART_v1.0,PIK3R3,mRNA,0,,,Phenotype;Persistence;Metabolism;Exhaustion;Activation;TCR signaling;T-cell migration;mTOR;MAPK and PI3K Signaling;JAK-STAT;Innate-like T-cells;Autophagy;Apoptosis,hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04070;hsa04071;hsa04072;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04261;hsa04370;hsa04380;hsa04510;hsa04550;hsa04611;hsa04620;hsa04630;hsa04650;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04670;hsa04722;hsa04725;hsa04750;hsa04810;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04921;hsa04923;hsa04930;hsa04931;hsa04932;hsa04933;hsa04960;hsa04973;hsa05100;hsa05142;hsa05145;hsa05146;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05169;hsa05200;hsa05203;hsa05205;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05230;hsa05231,,PIK3R3,,,,,
NM_005064.4:433,NS_Hs_CART_v1.0,CCL23,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062,,CCL23,,,,,
NM_005262.2:1314,NS_Hs_CART_v1.0,GFER,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,GFER,,,,,
NM_005508.4:672,NS_Hs_CART_v1.0,CCR4,mRNA,0,,,Toxicity;Activation;Chemokine Signaling,hsa04060;hsa04062;hsa05203,,CCR4,,,,,
NM_005535.1:976,NS_Hs_CART_v1.0,IL12RB1,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;Th1;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa05321,,IL12RB1,,,,,
NM_005755.2:826,NS_Hs_CART_v1.0,EBI3,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,,,EBI3,,,,,
NM_006356.2:160,NS_Hs_CART_v1.0,ATP5PD,mRNA,0,,,Metabolism;Oxidative phosphorylation;Mitochondrial biogenesis,hsa00190;hsa01100;hsa05010;hsa05012;hsa05016,,ATP5PD,,,,,
NM_007028.3:402,NS_Hs_CART_v1.0,TRIM31,mRNA,0,,,Toxicity;Type II interferon signaling,,,TRIM31,,,,,
NM_014507.3:378,NS_Hs_CART_v1.0,MCAT,mRNA,0,,,Metabolism;Lipid Metabolism,hsa00061;hsa01100;hsa01212,,MCAT,,,,,
NM_021079.3:1206,NS_Hs_CART_v1.0,NMT1,mRNA,0,,,Exhaustion;Apoptosis,,,NMT1,,,,,
NM_030807.4:492,NS_Hs_CART_v1.0,SLC2A11,mRNA,0,,,Metabolism;Glycolysis,,,SLC2A11,,,,,
NM_032783.4:520,NS_Hs_CART_v1.0,CBR4,mRNA,0,,,Metabolism;Lipid Metabolism,,,CBR4,,,,,
NM_144606.5:1100,NS_Hs_CART_v1.0,FLCN,mRNA,0,,,Metabolism;mTOR,hsa05211,,FLCN,,,,,
NM_173642.3:2324,NS_Hs_CART_v1.0,RIMKLA,mRNA,0,,,Metabolism;Glutamine metabolism,hsa00250;hsa01100,,RIMKLA,,,,,
NM_194260.2:304,NS_Hs_CART_v1.0,UBE2I,mRNA,0,,,Toxicity;Metabolism;NF-kB;Cell Cycle,hsa04064;hsa04120;hsa05206,,UBE2I,,,,,
NM_198329.2:778,NS_Hs_CART_v1.0,UBA5,mRNA,0,,,Activation;Antigen processing & presentation,,,UBA5,,,,,
NR_033757.2:3524,NS_Hs_CART_v1.0,MINOS1,mRNA,0,,,Metabolism;Mitochondrial biogenesis,,,MICOS10,,,,,
NR_037774.1:626,NS_Hs_CART_v1.0,STAM,mRNA,0,,,Activation;JAK-STAT,,,,,,,,
NM_001001928.2:266,NS_Hs_CART_v1.0,PPARA,mRNA,0,,,Metabolism;Mitochondrial biogenesis;Circadian Clock,hsa03320;hsa04024;hsa04920;hsa04922;hsa04931;hsa04932;hsa05160,,PPARA,,,,,
NM_001079526.1:3362,NS_Hs_CART_v1.0,IKZF2,mRNA,0,,,Phenotype;Th2,,,IKZF2,,,,,
NM_007334.2:2189,NS_Hs_CART_v1.0,KLRD1,mRNA,0,,,Toxicity;Exhaustion;Cell Types;NKT Receptors;Interactions with Non-lymphoid Cells;Cytotoxicity,hsa04612;hsa04650;hsa05332,Cytotoxic cells,KLRD1,,,,,
NM_032427.2:1890,NS_Hs_CART_v1.0,MAML2,mRNA,0,,,Phenotype;Th1;Notch,hsa04330,,MAML2,,,,,
NM_000043.4:398,NS_Hs_CART_v1.0,FAS,mRNA,0,,,Toxicity;Exhaustion;Activation;MAPK and PI3K Signaling;Cytotoxicity;Apoptosis,hsa04010;hsa04060;hsa04115;hsa04210;hsa04650;hsa04668;hsa04932;hsa04940;hsa05010;hsa05142;hsa05143;hsa05161;hsa05162;hsa05164;hsa05168;hsa05200;hsa05205;hsa05320;hsa05330;hsa05332,,FAS,,,,,
NM_001257397.1:453,NS_Hs_CART_v1.0,UBE2V1,mRNA,0,,,Activation;Antigen processing & presentation,,,UBE2V1,,,,,
NM_001040110.1:2910,NS_Hs_CART_v1.0,NRF1,mRNA,0,,,Metabolism;Activation;TCR signaling;Mitochondrial biogenesis,hsa05016,,NRF1,,,,,
NM_022148.3:852,NS_Hs_CART_v1.0,CRLF2,mRNA,0,,,Activation;JAK-STAT,hsa04060;hsa04630,,CRLF2,,,,,
NM_003331.4:1980,NS_Hs_CART_v1.0,TYK2,mRNA,0,,,Toxicity;Phenotype;Activation;Type I interferon signaling;Treg;Th17;Th1;JAK-STAT;Interleukin Signaling,hsa04380;hsa04630;hsa05145;hsa05160;hsa05162;hsa05164;hsa05168;hsa05169,,TYK2,,,,,
NM_000418.3:1510,NS_Hs_CART_v1.0,IL4R,mRNA,0,,,Toxicity;Phenotype;Activation;Th2;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04151;hsa04630;hsa04640;hsa05321,,IL4R,,,,,
NM_012483.3:945,NS_Hs_CART_v1.0,GNLY,mRNA,0,,,Cell Types,,Cytotoxic cells,GNLY,,,,,
NM_199139.2:313,NS_Hs_CART_v1.0,XAF1,mRNA,0,,,Toxicity;Type I interferon signaling,,,XAF1,,,,,
NM_130390.2:573,NS_Hs_CART_v1.0,TRIM34,mRNA,0,,,Toxicity;Type II interferon signaling,,,TRIM34,,,,,
NM_017414.3:334,NS_Hs_CART_v1.0,USP18,mRNA,0,,,Toxicity;Type I interferon signaling,,,USP18,,,,,
NM_021181.4:1122,NS_Hs_CART_v1.0,SLAMF7,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells,,,SLAMF7,,,,,
NM_033271.2:1536,NS_Hs_CART_v1.0,BTBD6,mRNA,0,,,Activation;Antigen processing & presentation,,,BTBD6,,,,,
NM_004972.3:1464,NS_Hs_CART_v1.0,JAK2,mRNA,0,,,Toxicity;Phenotype;Metabolism;Activation;Type II interferon signaling;Th17;Th1;MAPK and PI3K Signaling;JAK-STAT;Cell Cycle,hsa04062;hsa04151;hsa04550;hsa04630;hsa04725;hsa04917;hsa04920;hsa04933;hsa05140;hsa05145;hsa05152;hsa05162;hsa05164;hsa05168,,JAK2,,,,,
NM_005191.3:674,NS_Hs_CART_v1.0,CD80,mRNA,0,,,Phenotype;Exhaustion;Activation;Innate-like T-cells;Costimulatory Molecules,hsa04514;hsa04620;hsa04672;hsa04940;hsa05320;hsa05322;hsa05323;hsa05330;hsa05332;hsa05416,,CD80,,,,,
NM_000880.3:516,NS_Hs_CART_v1.0,IL7,mRNA,0,,,Toxicity;Activation;MAPK and PI3K Signaling;JAK-STAT;Interleukin Signaling,hsa04060;hsa04151;hsa04630;hsa04640,,IL7,,,,,
NM_001166663.1:22,NS_Hs_CART_v1.0,CD244,mRNA,0,,,Toxicity;Exhaustion;Cell Types;T-cell exhaustion markers;NKT Receptors;Cytotoxicity,hsa04650,Exhausted CD8,CD244,,,,,
NM_001098175.1:795,NS_Hs_CART_v1.0,ENTPD1,mRNA,0,,,Phenotype;Treg,hsa00230;hsa05169,,ENTPD1,,,,,
NM_014143.3:49,NS_Hs_CART_v1.0,CD274,mRNA,0,,,Exhaustion;Activation;Costimulatory Molecules,hsa04514,,CD274,,,,,
NM_003327.3:981,NS_Hs_CART_v1.0,TNFRSF4,mRNA,0,,,Exhaustion;Activation;Costimulatory Molecules,hsa04060,,TNFRSF4,,,,,
NM_005419.3:1390,NS_Hs_CART_v1.0,STAT2,mRNA,0,,,Toxicity;Activation;Type I interferon signaling;JAK-STAT,hsa04062;hsa04380;hsa04630;hsa05160;hsa05161;hsa05162;hsa05164;hsa05168,,STAT2,,,,,
NM_000402.4:923,NS_Hs_CART_v1.0,G6PD,mRNA,1,Housekeeping,,,,,G6PD,,,,,
NM_018955.3:1052,NS_Hs_CART_v1.0,UBB,mRNA,1,Housekeeping,,,,,UBB,,,,,
NM_017970.3:3233,NS_Hs_CART_v1.0,NRDE2,mRNA,1,Housekeeping,,,,,NRDE2,,,,,
NM_001090.2:857,NS_Hs_CART_v1.0,ABCF1,mRNA,1,Housekeeping,,,,,ABCF1,,,,,
NM_004168.3:342,NS_Hs_CART_v1.0,SDHA,mRNA,1,Housekeeping,,,,,SDHA,,,,,
NM_000875.4:4580,NS_Hs_CART_v1.0,IGF1R,mRNA,0,,,Metabolism;Activation;mTOR;MAPK and PI3K Signaling;Autophagy,hsa04014;hsa04015;hsa04066;hsa04068;hsa04114;hsa04144;hsa04151;hsa04152;hsa04211;hsa04213;hsa04510;hsa04520;hsa04550;hsa04730;hsa04914;hsa05200;hsa05202;hsa05205;hsa05214;hsa05215;hsa05218,,IGF1R,,,,,
XM_011545981.1:713,NS_Hs_CART_v1.0,CD19,mRNA,0,,,Exhaustion;Cell Types;Activation;MAPK and PI3K Signaling;Interactions with Non-lymphoid Cells,hsa04151;hsa04640;hsa04662;hsa05169;hsa05340,B-cells,CD19,,,,,
NM_004377.3:1654,NS_Hs_CART_v1.0,CPT1B,mRNA,0,,,Phenotype;Metabolism;Vitamin A (RA) signaling;Mitochondrial biogenesis;Lipid Metabolism,hsa00071;hsa01212;hsa03320;hsa04152;hsa04920;hsa04922;hsa04931,,CPT1B,,,,,
NM_001865.3:300,NS_Hs_CART_v1.0,COX7A2,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,COX7A2,,,,,
ENST00000390469.1:173,NS_Hs_CART_v1.0,TRDV2,mRNA,0,,,TCR Diversity,,,,,,,,
NM_001288968.1:1975,NS_Hs_CART_v1.0,ACSF2,mRNA,0,,,Metabolism;Lipid Metabolism,,,ACSF2,,,,,
NM_001284244.1:416,NS_Hs_CART_v1.0,PNOC,mRNA,0,,,Cell Types,,B-cells,PNOC,,,,,
NM_054025.2:1033,NS_Hs_CART_v1.0,B3GAT1,mRNA,0,,,Exhaustion;T-cell exhaustion markers,,,B3GAT1,,,,,
NM_001866.2:159,NS_Hs_CART_v1.0,COX7B,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,COX7B,,,,,
NM_002157.2:607,NS_Hs_CART_v1.0,HSPE1,mRNA,0,,,Metabolism;Activation;Myc targets;Mitochondrial biogenesis,,,HSPE1,,,,,
NM_002124.3:747,NS_Hs_CART_v1.0,HLA-DRB1,mRNA,0,,,Toxicity;Activation;Type II interferon signaling;Antigen processing & presentation,hsa04145;hsa04514;hsa04612;hsa04640;hsa04672;hsa04940;hsa05140;hsa05145;hsa05150;hsa05152;hsa05164;hsa05166;hsa05168;hsa05169;hsa05310;hsa05320;hsa05321;hsa05322;hsa05323;hsa05330;hsa05332;hsa05416,,HLA-DRB1,,,,,
NM_015259.5:642,NS_Hs_CART_v1.0,ICOSLG,mRNA,0,,,Exhaustion;Activation;Costimulatory Molecules,hsa04514;hsa04672,,ICOSLG,,,,,
ENST00000443402.1:984,NS_Hs_CART_v1.0,TRGC1,mRNA,0,,,TCR Diversity,,,,,,,,
ENST00000611116.1:361,NS_Hs_CART_v1.0,TRAC,mRNA,0,,,Exhaustion;TCR Diversity;Interactions with Non-lymphoid Cells,,,,,,,,
NM_012084.3:1370,NS_Hs_CART_v1.0,GLUD1/2,mRNA,0,,,Metabolism;Mitochondrial biogenesis;Glutamine metabolism,hsa00250;hsa01100;hsa01200,,GLUD2,,,,,
NM_001018077.1:2822,NS_Hs_CART_v1.0,NR3C1,mRNA,0,,,Metabolism;Circadian Clock,hsa04080,,NR3C1,,,,,
NM_000246.3:3047,NS_Hs_CART_v1.0,CIITA,mRNA,0,,,Toxicity;Type II interferon signaling,hsa04612;hsa05145;hsa05152;hsa05164;hsa05340,,CIITA,,,,,
NM_002872.4:341,NS_Hs_CART_v1.0,RAC2,mRNA,0,,,Toxicity;Phenotype;Persistence;Activation;Wnt signaling;T-cell migration;MAPK and PI3K Signaling;Cytotoxicity,hsa04010;hsa04014;hsa04015;hsa04024;hsa04062;hsa04071;hsa04310;hsa04360;hsa04370;hsa04510;hsa04520;hsa04650;hsa04662;hsa04664;hsa04666;hsa04670;hsa04810;hsa05200;hsa05210;hsa05212;hsa05231;hsa05416,,RAC2,,,,,
NM_001320984.1:281,NS_Hs_CART_v1.0,IL1R1,mRNA,0,,,Toxicity;Phenotype;Activation;Th17;NF-kB;MAPK and PI3K Signaling;Interleukin Signaling,hsa04010;hsa04060;hsa04064;hsa04210;hsa04380;hsa04640;hsa04750;hsa05146;hsa05166,,IL1R1,,,,,
NM_181079.4:1250,NS_Hs_CART_v1.0,IL21R,mRNA,0,,,Toxicity;Phenotype;Cell Types;Activation;Th17;Tfh;JAK-STAT;Interleukin Signaling,hsa04060;hsa04630;hsa05321,NK CD56dim cells,IL21R,,,,,
NM_002414.4:592,NS_Hs_CART_v1.0,CD99,mRNA,0,,,Persistence;Exhaustion;T-cell migration;Interactions with Non-lymphoid Cells,hsa04514;hsa04670,,CD99,,,,,
NM_000282.3:303,NS_Hs_CART_v1.0,PCCA,mRNA,0,,,Metabolism;Lipid Metabolism,hsa00630;hsa01100;hsa01200,,PCCA,,,,,
XM_017024034.1:384,NS_Hs_CART_v1.0,CD300C,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,,,CD300C,,,,,
NM_001329099.1:462,NS_Hs_CART_v1.0,KLRG1,mRNA,0,,,Toxicity;Exhaustion;T-cell exhaustion markers;NKT Receptors;Interactions with Non-lymphoid Cells,,,KLRG1,,,,,
NM_005957.4:1040,NS_Hs_CART_v1.0,MTHFR,mRNA,0,,,Metabolism;One-carbon metabolism,hsa00670;hsa01100;hsa01200,,MTHFR,,,,,
NM_001293557.1:652,NS_Hs_CART_v1.0,NOD2,mRNA,0,,,Toxicity;Activation;Interleukin Signaling,hsa04621;hsa04668;hsa05131;hsa05152;hsa05321,,NOD2,,,,,
NM_001278426.3:591,NS_Hs_CART_v1.0,LILRB4,mRNA,0,,,Exhaustion;T-cell exhaustion markers;Interactions with Non-lymphoid Cells,hsa04380,,LILRB4,,,,,
NM_001278318.1:486,NS_Hs_CART_v1.0,LILRA1,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa04380,,LILRA1,,,,,
NM_016523.2:101,NS_Hs_CART_v1.0,KLRF1,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells,,,KLRF1,,,,,
NM_020328.3:564,NS_Hs_CART_v1.0,ACVR1B,mRNA,0,,,Phenotype;TGF-beta,hsa04060;hsa04350;hsa04550,,ACVR1B,,,,,
NM_001184714.1:903,NS_Hs_CART_v1.0,SLAMF6,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells,,,SLAMF6,,,,,
NM_198053.2:329,NS_Hs_CART_v1.0,CD247,mRNA,0,,,Toxicity;Activation;TCR signaling;NKT Receptors;Cytotoxicity,hsa04650;hsa04660;hsa05142,,CD247,,,,,
NM_001242.4:1101,NS_Hs_CART_v1.0,CD27,mRNA,0,,,Toxicity;Phenotype;Exhaustion;Activation;Naïve Markers;NKT Receptors;Costimulatory Molecules,hsa04060,,CD27,,,,,
NM_001114633.1:61,NS_Hs_CART_v1.0,PLA2G4B,mRNA,0,,,Activation;MAPK and PI3K Signaling,hsa01100;hsa04010;hsa04014;hsa04072;hsa04270;hsa04370;hsa04611;hsa04664;hsa04666;hsa04724;hsa04726;hsa04730;hsa04750;hsa04912;hsa04921;hsa05231,,PLA2G4B,,,,,
NM_001159488.1:132,NS_Hs_CART_v1.0,FCRL2,mRNA,0,,,Cell Types,,B-cells,FCRL2,,,,,
ENST00000444775.1:434,NS_Hs_CART_v1.0,TRGV9,mRNA,0,,,TCR Diversity,,,,,,,,
NM_001136031.2:406,NS_Hs_CART_v1.0,ATG7,mRNA,0,,,Metabolism;Activation;Mitochondrial biogenesis;Autophagy;Antigen processing & presentation,hsa04140,,ATG7,,,,,
NM_002905.3:228,NS_Hs_CART_v1.0,RDH5,mRNA,0,,,Phenotype;Vitamin A (RA) signaling,,,RDH5,,,,,
NM_001318797.1:50,NS_Hs_CART_v1.0,COX4I1,mRNA,0,,,Metabolism;Oxidative phosphorylation,hsa00190;hsa01100;hsa04260;hsa04932;hsa05010;hsa05012;hsa05016,,COX4I1,,,,,
ENST00000390452.1:247,NS_Hs_CART_v1.0,TRDV1,mRNA,0,,,TCR Diversity,,,,,,,,
NM_001177608.1:866,NS_Hs_CART_v1.0,CD33,mRNA,0,,,Toxicity;Exhaustion;NKT Receptors;Interactions with Non-lymphoid Cells,hsa04640,,CD33,,,,,
ENST00000535880.1:287,NS_Hs_CART_v1.0,TRDV3,mRNA,0,,,TCR Diversity,,,,,,,,
NM_004059.4:1557,NS_Hs_CART_v1.0,KYAT1,mRNA,0,,,Metabolism;Glutamine metabolism,hsa01100,,KYAT1,,,,,
TCRVA_043.1:14,NS_Hs_CART_v1.0,TRAV38-2,mRNA,0,,,TCR Diversity,,,,,,,,
ENST00000390364.1:83,NS_Hs_CART_v1.0,TRBV10-1,mRNA,0,,,TCR Diversity,,,,,,,,
ENST00000390371.1:163,NS_Hs_CART_v1.0,TRBV6-6,mRNA,0,,,TCR Diversity,,,,,,,,
ENST00000426402.1:378,NS_Hs_CART_v1.0,TRGV2,mRNA,0,,,TCR Diversity,,,,,,,,
ENST00000390346.1:376,NS_Hs_CART_v1.0,TRGV3/5,mRNA,0,,,TCR Diversity,,,,,,,,
ENST00000390343.1:316,NS_Hs_CART_v1.0,TRGV8,mRNA,0,,,TCR Diversity,,,,,,,,
NM_003830.3:1405,NS_Hs_CART_v1.0,SIGLEC5,mRNA,0,,,Exhaustion;Cell Types;Interactions with Non-lymphoid Cells,,Neutrophils,SIGLEC5,,,,,
NM_002198.2:15,NS_Hs_CART_v1.0,IRF1,mRNA,0,,,Toxicity;Type II interferon signaling;Type I interferon signaling,hsa04917;hsa05133;hsa05160,,IRF1,,,,,
NM_001252078.1:154,NS_Hs_CART_v1.0,USP15,mRNA,0,,,Phenotype;TGF-beta,,,USP15,,,,,
NM_001017998.3:69,NS_Hs_CART_v1.0,GNG10,mRNA,0,,,Phenotype;Activation;Wnt signaling;MAPK and PI3K Signaling,hsa04014;hsa04062;hsa04151;hsa04713;hsa04723;hsa04724;hsa04725;hsa04726;hsa04727;hsa04728;hsa05032;hsa05034;hsa05200,,GNG10,,,,,
NM_001018025.3:795,NS_Hs_CART_v1.0,MTCP1,mRNA,0,,,Activation;MAPK and PI3K Signaling,hsa04151,,MTCP1,,,,,
NM_004892.5:85,NS_Hs_CART_v1.0,SEC22B,mRNA,0,,,Activation;Antigen processing & presentation,hsa04145;hsa05134,,SEC22B,,,,,
NM_002787.4:460,NS_Hs_CART_v1.0,PSMA2,mRNA,0,,,Phenotype;Metabolism;Exhaustion;Activation;Wnt signaling;Notch;Cell Cycle;Apoptosis;Antigen processing & presentation,hsa03050,,PSMA2,,,,,
NM_006864.3:1102,NS_Hs_CART_v1.0,LILRB3,mRNA,0,,,Exhaustion;Interactions with Non-lymphoid Cells,hsa04380;hsa04662,,LILRB3,,,,,
NM_005018.2:570,NS_Hs_CART_v1.0,PDCD1,mRNA,0,,,Exhaustion;Activation;TCR signaling;T-cell exhaustion markers;Costimulatory Molecules,hsa04514;hsa04660,,PDCD1,,,,,
ERCC_00154.1:115,ALL,NEG_H(0),mRNA,1,Negative,,,,,,,,,,
ERCC_00041.1:440,ALL,NEG_B(0),mRNA,1,Negative,,,,,,,,,,
ERCC_00098.1:785,ALL,NEG_E(0),mRNA,1,Negative,,,,,,,,,,
ERCC_00126.1:220,ALL,NEG_F(0),mRNA,1,Negative,,,,,,,,,,
ERCC_00096.1:230,ALL,NEG_A(0),mRNA,1,Negative,,,,,,,,,,
ERCC_00076.1:355,ALL,NEG_D(0),mRNA,1,Negative,,,,,,,,,,
ERCC_00144.1:15,ALL,NEG_G(0),mRNA,1,Negative,,,,,,,,,,
ERCC_00019.1:140,ALL,NEG_C(0),mRNA,1,Negative,,,,,,,,,,
ERCC_00092.1:540,ALL,POS_D(2),mRNA,1,Positive,,,,,,,,,,
ERCC_00112.1:695,ALL,POS_B(32),mRNA,1,Positive,,,,,,,,,,
ERCC_00002.1:850,ALL,POS_C(8),mRNA,1,Positive,,,,,,,,,,
ERCC_00035.1:485,ALL,POS_E(0.5),mRNA,1,Positive,,,,,,,,,,
ERCC_00034.1:195,ALL,POS_F(0.125),mRNA,1,Positive,,,,,,,,,,
ERCC_00117.1:385,ALL,POS_A(128),mRNA,1,Positive,,,,,,,,,,
purespike1.1:0,ALL,purespike1.1,mRNA,1,,,,,,,,,,,
purespike3.1:0,ALL,purespike3.1,mRNA,1,,,,,,,,,,,
purespike2.1:0,ALL,purespike2.1,mRNA,1,,,,,,,,,,,